[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 375
1. Tryggvason G, Kristmundsson T, Orvar K, Jónasson JG, Magnússon MK, Gíslason HG: Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003. Dig Dis Sci; 2007 Sep;52(9):2249-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003.
  • All mesenchymal tumors in the digestive tract diagnosed from 1990 to 2003 were identified.
  • All reports were reviewed, all tumors were stained with antibodies to c-kit, and the diagnosis of GIST was confirmed.
  • The mean age at diagnosis was 65.8+/-13.6 years (SD).
  • Tumor distribution included 62% in the upper, 32% in the middle, and 6% in the lower digestive tract.
  • Mean tumor size was 4.9+/-4.4 cm (SD).
  • Gastrointestinal (GI) bleeding was the main symptom in 53% (20/38) of symptomatic cases; most presented with acute gastrointestinal bleeding.
  • Eight of the 53 tumors (15.1%) metastasized, 7 of which were nongastric.
  • We conclude that GISTs are often found incidentally but GI bleeding is the most common presentation.
  • Five-year survival is better than previously reported and gastric GIST seems to be more benign than nongastric.
  • [MeSH-major] Gastrointestinal Stromal Tumors
  • [MeSH-minor] Adult. Age Distribution. Aged. Aged, 80 and over. Antibodies, Neoplasm / analysis. Digestive System Surgical Procedures / methods. Female. Follow-Up Studies. Humans. Iceland / epidemiology. Incidence. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Neoplasm Staging. Prognosis. Proto-Oncogene Proteins c-kit / immunology. Retrospective Studies. Sex Distribution. Survival Rate. Time Factors

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 2000 Jan;231(1):51-8 [10636102.001]
  • [Cites] Ann Surg Oncol. 2001 Jan-Feb;8(1):50-9 [11206225.001]
  • [Cites] Arch Surg. 2001 Apr;136(4):383-9 [11296107.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] Hum Pathol. 2002 May;33(5):459-65 [12094370.001]
  • [Cites] Clin Cancer Res. 2003 Aug 15;9(9):3329-37 [12960119.001]
  • [Cites] Am J Pathol. 1998 May;152(5):1259-69 [9588894.001]
  • [Cites] Science. 1998 Jan 23;279(5350):577-80 [9438854.001]
  • [Cites] Int J Cancer. 2005 Nov 1;117(2):289-93 [15900576.001]
  • [Cites] Ann Surg. 1987 Dec;206(6):706-10 [3689007.001]
  • [Cites] Cancer. 2005 Feb 15;103(4):821-9 [15648083.001]
  • [Cites] Am J Surg Pathol. 1999 Jan;23(1):82-7 [9888707.001]
  • [Cites] Cancer Res. 2001 Nov 15;61(22):8118-21 [11719439.001]
  • [Cites] Lab Invest. 2004 Jul;84(7):874-83 [15146165.001]
  • [Cites] Ann Surg. 1992 Jan;215(1):68-77 [1731651.001]
  • (PMID = 17420941.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Neoplasm; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


2. Nosrati N, Coleman NM, Hsu S: Axillary syringomas. Dermatol Online J; 2008;14(4):13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Syringomas are common benign neoplasms encountered mostly around the eyes.
  • However, as described herein, these tumors can occur in atypical locations such as the axilla.
  • The differential diagnosis revolves around those entities more likely seen in this anatomical location (such as Fox-Fordyce, Hailey-Hailey and Darier diseases).
  • [MeSH-major] Sweat Gland Neoplasms / diagnosis. Syringoma / diagnosis
  • [MeSH-minor] Adult. Axilla / pathology. Diagnosis, Differential. Female. Humans. Sex Factors. Skin / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18627735.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Xing BC, Sun Y, Bao Q, Qian HG, Hao CY, Huang XF, Wang Y, Gu J, Ji JF: [Spleen-preserving distal pancreatectomy in treatment of solid-pseudopapillary neoplasm]. Zhonghua Yi Xue Za Zhi; 2006 Mar 14;86(10):690-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spleen-preserving distal pancreatectomy in treatment of solid-pseudopapillary neoplasm].
  • OBJECTIVE: To investigate the feasibility and safety of spleen-preserving distal pancreatectomy with conservation of the splenic arteries and veins in treatment of benign neoplasms of distal pancreas.
  • METHODS: Four patients with solid-pseudopapillary neoplasm, 1 males and 3 females, aged 30 (17 - 37), underwent laparotomy.
  • The distal pancreas with tumor was cut.
  • CONCLUSION: Safe and feasible, spleen-preserving distal pancreatectomy with conservation of the splenic arteries and veins is one of the best choices for treatment of benign and borderline tumors of pancreas.
  • [MeSH-major] Carcinoma, Papillary / surgery. Pancreatectomy / methods. Pancreatic Neoplasms / surgery

  • Genetic Alliance. consumer health - Spleen neoplasm.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681929.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


Advertisement
4. Hassounah M, Lach B, Allam A, Al-Khalaf H, Siddiqui Y, Pangue-Cruz N, Al-Omeir A, Al-Ahdal MN, Aboussekhra A: Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis. J Neurooncol; 2005 May;72(3):203-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis.
  • Here we have assessed the level of the survivin protein in some benign tumors of the nervous system: meningioma, schwannoma, low-grade ependymoma, pilocytic astrocytoma and pituitary adenoma.
  • Using immuno-blot analysis we present evidence that these low-grade tumors are positive for survivin expression.
  • In agreement, flow cytometrical analysis showed that both spontaneous and radiation-induced apoptosis levels are very low in these neoplasms.
  • Using host cell reactivation assay we have also shown that these tumor cells are proficient in the repair of gamma-ray-induced DNA damage.
  • These results suggest that survivin overexpression may be an early event in the stepwise tumoregenesis and hence could be responsible for the onset as well as the growth advantage during tumoregenic progression of malignant as well as benign neoplasms.
  • [MeSH-major] Apoptosis / physiology. Apoptosis / radiation effects. Microtubule-Associated Proteins / biosynthesis. Nervous System Neoplasms / metabolism. Nervous System Neoplasms / pathology
  • [MeSH-minor] Cell Line, Tumor. DNA Damage / radiation effects. Electrophoresis, Polyacrylamide Gel. Flow Cytometry. Gamma Rays. Genes, p53 / genetics. Genes, p53 / radiation effects. Humans. Immunoblotting. Inhibitor of Apoptosis Proteins. Neoplasm Proteins / metabolism. Oncogene Protein p21(ras) / biosynthesis. Oncogene Protein p21(ras) / radiation effects. Tumor Cells, Cultured. Ultraviolet Rays

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurooncol. 2004 Mar-Apr;67(1-2):209-14 [15072469.001]
  • [Cites] Oncogene. 2004 Apr 12;23(16):2809-18 [15077144.001]
  • [Cites] J Neurooncol. 2003 Aug-Sep;64(1-2):71-6 [12952288.001]
  • [Cites] Semin Cancer Biol. 1998;8(5):345-57 [10101800.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):635-40 [11149963.001]
  • [Cites] J Clin Invest. 2001 Oct;108(7):991-9 [11581300.001]
  • [Cites] Cell. 2000 Jan 7;100(1):57-70 [10647931.001]
  • [Cites] Cell. 1993 Nov 19;75(4):817-25 [8242752.001]
  • [Cites] Oncogene. 2002 Apr 18;21(17):2613-22 [11965534.001]
  • [Cites] Cancer Res. 1998 Dec 1;58(23):5315-20 [9850056.001]
  • [Cites] Nature. 1998 Dec 10;396(6711):580-4 [9859993.001]
  • [Cites] Nat Genet. 1999 Dec;23(4):387-8 [10581018.001]
  • [Cites] Oncogene. 1999 Dec 13;18(53):7621-36 [10618702.001]
  • [Cites] J Biol Chem. 2002 Feb 1;277(5):3247-57 [11714700.001]
  • [Cites] Oncogene. 2003 Nov 24;22(53):8581-9 [14634620.001]
  • [Cites] Mutat Res. 1976 Apr;35(1):13-22 [178998.001]
  • [Cites] Curr Opin Oncol. 2001 May;13(3):160-6 [11307058.001]
  • [Cites] Nat Med. 1997 Aug;3(8):917-21 [9256286.001]
  • [Cites] Nat Rev Cancer. 2003 Jan;3(1):46-54 [12509766.001]
  • [Cites] Cell. 2002 Jan 25;108(2):153-64 [11832206.001]
  • (PMID = 15937641.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins; EC 3.6.5.2 / Oncogene Protein p21(ras)
  •  go-up   go-down


5. Ritter MR, Reinisch J, Friedlander SF, Friedlander M: Myeloid cells in infantile hemangioma. Am J Pathol; 2006 Feb;168(2):621-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Little is known about the pathogenesis of infantile hemangiomas despite the fact that they are relatively common tumors.
  • These benign neoplasms occur in as many as 1 in 10 births, and although rarely life threatening, hemangiomas can pose serious concerns to the cosmetic and psychosocial development of the afflicted child.

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Leukoc Biol. 2001 Oct;70(4):478-90 [11590184.001]
  • [Cites] Mol Med. 2004 Jul-Dec;10(7-12):117-23 [15706404.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 May 28;99(11):7455-60 [12032304.001]
  • [Cites] Blood Cells Mol Dis. 2002 Mar-Apr;28(2):152-9 [12064911.001]
  • [Cites] Am J Reprod Immunol. 2002 Aug;48(2):110-6 [12389600.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2003 Mar;30(3):140-4 [12603341.001]
  • [Cites] Adv Exp Med Biol. 2003;522:47-57 [12674210.001]
  • [Cites] Am J Reprod Immunol. 2003 Mar;49(3):129-38 [12797519.001]
  • [Cites] Arch Dermatol. 2003 Jul;139(7):869-75 [12873881.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1373-5 [14576053.001]
  • [Cites] Plast Reconstr Surg. 2004 Mar;113(3):999-1011 [15108898.001]
  • [Cites] Hum Pathol. 2004 Jun;35(6):739-44 [15188141.001]
  • [Cites] J Am Acad Dermatol. 2004 Jul;51(1 Suppl):S50-2 [15243511.001]
  • [Cites] Mod Pathol. 2004 Sep;17(9):1068-79 [15143338.001]
  • [Cites] Plast Reconstr Surg. 1982 Mar;69(3):412-22 [7063565.001]
  • [Cites] J Immunol. 1987 Nov 15;139(10):3536-41 [2960735.001]
  • [Cites] J Immunol. 1990 Feb 15;144(4):1304-10 [2137489.001]
  • [Cites] Diabetes. 1992 Feb;41(2):227-34 [1733814.001]
  • [Cites] Pharmacol Ther. 1991;51(2):195-216 [1784630.001]
  • [Cites] Am J Physiol. 1992 Aug;263(2 Pt 1):C326-33 [1514581.001]
  • [Cites] Metabolism. 1994 May;43(5):591-8 [8177047.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2588-92 [8637918.001]
  • [Cites] Cancer Res. 1999 Aug 15;59(16):3915-8 [10463582.001]
  • [Cites] J Immunol. 1999 Sep 15;163(6):3484-90 [10477621.001]
  • [Cites] Hum Pathol. 2000 Jan;31(1):11-22 [10665907.001]
  • [Cites] Hum Pathol. 2000 Jun;31(6):691-7 [10872662.001]
  • [Cites] Differentiation. 2000 May;65(5):287-300 [10929208.001]
  • [Cites] J Clin Invest. 2001 Mar;107(6):745-52 [11254674.001]
  • [Cites] Arch Dermatol. 2001 May;137(5):559-70 [11346333.001]
  • [Cites] Lymphat Res Biol. 2003;1(4):291-9 [15624557.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Mar;33(3):295-303 [11807987.001]
  • (PMID = 16436675.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / F32 EY013916; United States / NEI NIH HHS / EY / R01 EY011254; United States / NEI NIH HHS / EY / F32 EY13916; United States / NEI NIH HHS / EY / R01 EY11254
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD14; 0 / Antigens, CD15; 0 / CD83 antigen; 0 / Immunoglobulins; 0 / Membrane Glycoproteins; 0 / Receptors, IgG
  • [Other-IDs] NLM/ PMC1606494
  •  go-up   go-down


6. Bellolio J E, Guzmán G P, Orellana C J, Roa S JC, Villaseca H M, Araya O JC, Tapia E O, Ineda N V: [Diagnostic value of frozen section biopsy during surgery for breast lesions or neoplasms]. Rev Med Chil; 2009 Sep;137(9):1173-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic value of frozen section biopsy during surgery for breast lesions or neoplasms].
  • [Transliterated title] Validez diagnóstica de la biopsia intraoperatoria en cirugía de lesiones mamarias palpables.
  • BACKGROUND: During the surgical treatment of breast neoplasms (benign or malignant), frozen section biopsy is frequently requested to assess the kind of lesion and determine the surgical margins.
  • MATERIAL AND METHODS: AH the pathological reports of frozen section biopsies and definitive biopsies of 337 women aged 26 to 88 years, operated for suspected breast neoplasms between 2002 and 2006, were reviewed.
  • The diagnosis of phyllodes tumor was missed by frozen section biopsy in three cases.
  • [MeSH-major] Biopsy / methods. Breast Neoplasms / pathology. Frozen Sections / standards. Intraoperative Care / methods

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20011957.001).
  • [ISSN] 0034-9887
  • [Journal-full-title] Revista médica de Chile
  • [ISO-abbreviation] Rev Med Chil
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Chile
  •  go-up   go-down


7. Schmitz-Feuerhake I, Pflugbeil S, Pflugbeil C: [Radiation risks from diagnostic radiology: meningiomas and other late effects after exposure of the skull]. Gesundheitswesen; 2010 Apr;72(4):246-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Radiation risks from diagnostic radiology: meningiomas and other late effects after exposure of the skull].
  • [Transliterated title] Röntgenrisiko: Abschätzung der strahleninduzierten Meningeome und anderer Spätschäden bei Exposition des Schädels.
  • A complete assessment of late effects of X-ray diagnostics should take into account that radiation sensitivity varies considerably for the different ages at exposure and, furthermore, that not only malignant diseases but also benign neoplasms are induced which also may lead to severe detriment of the patient.
  • Dose-effect relationships for tumours of the brain, skin, thyroid, and other sites of the head region, leukaemia, and cataracts are taken from the literature.
  • 1,000 annual paediatric CT investigations of the skull will lead to about 3 excess neoplasms in the head region, i.e., the probability of an induced late effect must be suspected in the range of some thousandths.
  • The radiation-induced occurrence of meningiomas and other brain tumours most probably contributes to the continuously increasing incidence of these diseases which is observed in several industrial nations, as well as the exposure of the bone marrow by CT to the increase of childhood leukaemia.
  • [MeSH-major] Brain Neoplasms / etiology. Brain Neoplasms / radiography. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology. Skull / radiation effects. Tomography, X-Ray Computed / adverse effects

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Georg Thieme Verlag KG Stuttgart, New York.
  • (PMID = 19551621.001).
  • [ISSN] 1439-4421
  • [Journal-full-title] Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany))
  • [ISO-abbreviation] Gesundheitswesen
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


8. Joyner DE, Wade ML, Szabo A, Bastar J, Coffin CM, Albritton KH, Bernard PS, Randall RL: Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo. J Cancer Res Clin Oncol; 2005 Mar;131(3):137-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.
  • BACKGROUND: Mesenchymal neoplasia comprises a heterogeneous group of tumors with over 200 benign neoplasms and 100 sarcomas.
  • Currently, tumors are classified using histologic and immunocytologic characteristics, with diagnostic error rates reported as high as 40% of cases.
  • As a feasibility study, our goal was to generate a preliminary discriminatory gene list for selected mesenchymal tumors, including sarcomas.
  • This technique may enable an eventual molecular classification schema based on expression profiles that can complement current clinical and pathologic diagnostic procedures in mesenchymal tumors.
  • METHODS: cDNA microarray analyses were preformed on connective tissue tumors obtained at time of surgical resection or biopsy.
  • Messenger RNA (mRNA) from four general tumor classes was competitively hybridized against a human dermal fibroblast cell line comparator and the resulting gene expression profiles processed by ANOVA and linear discriminate analysis.
  • RESULTS: The tissue classification involved 18 patients with malignant peripheral nerve sheath tumors, giant cell containing tumors, benign spindle cell lesions, or Ewing's family of tumors.
  • CONCLUSIONS: Linear discriminate analysis of cDNA gene expression profiles partitioned mesenchymal tumor classes, even when constrained by limited sample sizes.
  • [MeSH-major] DNA Fingerprinting. DNA, Neoplasm / analysis. Mesenchymoma / diagnosis. Mesenchymoma / genetics. Neoplasms, Connective Tissue / diagnosis. Neoplasms, Connective Tissue / genetics. Oligonucleotide Array Sequence Analysis
  • [MeSH-minor] Analysis of Variance. Carcinoma / diagnosis. Carcinoma / genetics. Carcinoma, Giant Cell / diagnosis. Carcinoma, Giant Cell / genetics. Cell Line. Feasibility Studies. Fibroblasts. Gene Expression Regulation, Neoplastic. Humans. Linear Models. Nerve Sheath Neoplasms / diagnosis. Nerve Sheath Neoplasms / genetics. RNA, Messenger / analysis. RNA, Neoplasm / analysis. Sarcoma, Ewing / diagnosis. Sarcoma, Ewing / genetics. Skin / cytology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1256-60 [11888886.001]
  • [Cites] Science. 1996 Aug 30;273(5279):1236-8 [8703060.001]
  • [Cites] Am J Clin Pathol. 2001 Oct;116(4):473-6 [11601130.001]
  • [Cites] Cell. 2000 Oct 13;103(2):211-25 [11057895.001]
  • [Cites] J Biol Chem. 1990 Feb 15;265(5):2665-70 [2406238.001]
  • [Cites] J Clin Oncol. 2002 Mar 1;20(5):1329-34 [11870176.001]
  • [Cites] Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S110-9 [14600600.001]
  • [Cites] Lancet. 2002 Apr 13;359(9314):1301-7 [11965276.001]
  • [Cites] Math Biosci. 2002 Mar;176(1):71-98 [11867085.001]
  • [Cites] Cancer Res. 2001 Sep 15;61(18):6649-55 [11559528.001]
  • [Cites] J Comput Biol. 2000;7(6):819-37 [11382364.001]
  • [Cites] Clin Cancer Res. 2000 Dec;6(12):4776-81 [11156234.001]
  • [Cites] J Cell Physiol. 2003 May;195(2):309-21 [12652657.001]
  • [Cites] Cancer Control. 2001 May-Jun;8(3):239-51 [11378650.001]
  • [Cites] J Clin Oncol. 1999 Dec;17(12):3695-6 [10577840.001]
  • [Cites] Annu Rev Cell Dev Biol. 2003;19:207-35 [14570569.001]
  • [Cites] Hum Mutat. 2000;16(1):18-22 [10874300.001]
  • [Cites] J Cell Biochem. 2000 Jun 12;78(4):627-37 [10861860.001]
  • [Cites] Cancer Cell. 2002 Sep;2(3):175-8 [12242149.001]
  • [Cites] FASEB J. 1999 May;13(8):781-92 [10224222.001]
  • [Cites] Nat Med. 2001 Jun;7(6):673-9 [11385503.001]
  • [Cites] Bioinformatics. 2003 Jan;19(1):53-61 [12499293.001]
  • [Cites] Cancer Res. 2002 Oct 15;62(20):5859-66 [12384549.001]
  • [Cites] Cancer Res. 2002 Apr 15;62(8):2281-6 [11956084.001]
  • [Cites] Curr Opin Cell Biol. 1995 Oct;7(5):728-35 [8573349.001]
  • [Cites] Nature. 2000 Feb 3;403(6769):503-11 [10676951.001]
  • [Cites] Annu Rev Cell Dev Biol. 2001;17:463-516 [11687497.001]
  • [Cites] Clin Orthop Relat Res. 2003 Oct;(415):59-63 [14612630.001]
  • [Cites] J Cell Physiol. 1999 May;179(2):170-8 [10199556.001]
  • [Cites] Oncogene. 1999 Mar 4;18(9):1771-6 [10208438.001]
  • [Cites] Oncogene. 1995 Apr 6;10(7):1461-3 [7731700.001]
  • [Cites] Cancer Res. 2003 Jul 1;63(13):3539-45 [12839939.001]
  • [Cites] J Cell Biol. 2000 Feb 21;148(4):779-90 [10684258.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):1791-5 [11280724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 [11309499.001]
  • [Cites] Am J Pathol. 1998 Jul;153(1):91-101 [9665469.001]
  • [Cites] Cancer Res. 1999 Nov 15;59(22):5656-61 [10582678.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13085-9 [12351679.001]
  • [Cites] J Clin Oncol. 1983 Aug;1(8):496-509 [6366142.001]
  • (PMID = 15614524.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


9. Cavaliere R, Lopes MB, Schiff D: Low-grade gliomas: an update on pathology and therapy. Lancet Neurol; 2005 Nov;4(11):760-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Low-grade gliomas (LGG) are not benign neoplasms.
  • [MeSH-major] Brain Neoplasms / pathology. Brain Neoplasms / therapy. Glioma / pathology. Glioma / therapy

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16239183.001).
  • [ISSN] 1474-4422
  • [Journal-full-title] The Lancet. Neurology
  • [ISO-abbreviation] Lancet Neurol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 119
  •  go-up   go-down


10. Stringer MD, Alizai NK: Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg; 2005 Nov;40(11):1681-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mesenchymal hamartoma of the liver is the second commonest benign liver tumor in children, yet its biology and pathogenesis are poorly understood.
  • Cytogenetic studies have suggested that the tumor may be a neoplasm rather than a hamartoma.
  • Typically, it presents as a large benign multicystic liver mass in a child younger than 3 years amenable to complete resection.
  • In addition, the tumor occasionally contains angiomatous elements or is multifocal.
  • Most tumors gradually increase in size, some reaching enormous proportions, which can make surgery challenging.
  • [MeSH-major] Hamartoma. Liver Neoplasms. Prenatal Diagnosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Prenatal Testing.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16291152.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 107
  •  go-up   go-down


11. Ducic Y, Oxford L, Pontius AT: Transoral approach to the superomedial parapharyngeal space. Otolaryngol Head Neck Surg; 2006 Mar;134(3):466-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To present our early experience with the transoral approach to the superomedial parapharyngeal space (PPS) and describe our technique for removal of these neoplasms.
  • METHODS: Eight patients with various neoplasms of the superomedial PPS were retrospectively reviewed for type of neoplasm, size, success with the transoral approach, need for conversion to another approach, length of hospitalization, and complications.
  • RESULTS: The transoral approach described herein safely allowed for en bloc resection of benign neoplasms with intraoperative control and exposure of the internal carotid artery.
  • Mean tumor size was 3.3 cm (range, 1.5 to 7 cm).
  • This technique is indicated for neoplasms with benign appearance on preoperative imaging or fine needle aspiration.
  • [MeSH-major] Mouth / surgery. Pharyngeal Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Biopsy, Needle. Carotid Artery, Internal / pathology. Child. Female. Follow-Up Studies. Humans. Intraoperative Care. Length of Stay. Male. Middle Aged. Neoplasm Invasiveness. Neurilemmoma / pathology. Neurilemmoma / surgery. Postoperative Complications. Retrospective Studies. Teratoma / pathology. Teratoma / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16500446.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Baichi MM, Arifuddin RM, Mantry PS: Small-bowel masses found and missed on capsule endoscopy for obscure bleeding. Scand J Gastroenterol; 2007 Sep;42(9):1127-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Data on the nature of small-bowel tumors found or missed by capsule endoscopy (CE) are limited.
  • The aim of this study was to review the CE findings in patients with small-bowel tumors presenting as obscure gastrointestinal (GI) bleeding.
  • MATERIAL AND METHODS: We retrospectively reviewed the medical records of the first 300 patients who underwent CE for obscure bleeding (non-diagnostic EGD and colonoscopy) at our institution.
  • Most (80%) of the lesions were potentially malignant: adenocarcinoma (n=4), neuroendocrine carcinoma (n=1), leiomyosarcoma (n=1), and GI stroma cell tumors (GISTs) (n=2).
  • Benign lesions included inflammatory fibroid polyp (n=1) and lipoma (n=1).
  • CE findings led directly to tumor diagnosis in 7 of the 10 cases.
  • CONCLUSIONS: Small-bowel tumors are a rare but serious source of obscure GI bleeding.
  • Tumors can have an atypical appearance including focal ulceration, nodularity, or active bleeding without a clear lesion.
  • [MeSH-major] Capsule Endoscopy. Intestinal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Female. Gastrointestinal Hemorrhage / etiology. Humans. Intestine, Small. Male. Middle Aged. Retrospective Studies. Treatment Outcome


13. Biswas D, Crank S: Aetiopathology of maxillary swelling--a 3-year prospective study. Eur Arch Otorhinolaryngol; 2007 Nov;264(11):1295-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A wide variety of lesions and not necessarily a malignant tumour can cause maxillary swelling.
  • Non-specificity of clinical and radiological features of these maxillary lesions makes their diagnosis difficult.
  • The awareness of the spectrum of pathology related to maxillary swelling is essential for correct diagnosis and treatment.
  • Maxillary swelling was found to be caused by malignant tumours in 54.2%, benign neoplasms in 22.9% and non-neoplastic lesions in 22.9%.
  • Overall squamous cell carcinoma (22.9%) was the commonest lesion, tumour of vascular origin was the commonest benign neoplasm and odontogenic cyst was the commonest among the non-neoplastic lesions.

  • MedlinePlus Health Information. consumer health - Edema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1978 Aug;88(8 Pt 1):1320-32 [672364.001]
  • [Cites] AJNR Am J Neuroradiol. 1995 Feb;16(2):333-8 [7726082.001]
  • [Cites] Radiology. 1977 Oct;125(1):149-58 [197566.001]
  • [Cites] Transplant Proc. 2006 Jun;38(5):1445-7 [16797328.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1997 Jun 20;40(2-3):181-7 [9225186.001]
  • [Cites] Indian J Dent Res. 2001 Jan-Mar;12(1):41-5 [11441801.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Clin Pathol. 1996 Feb;49(2):164-7 [8655685.001]
  • [Cites] Br J Oral Maxillofac Surg. 1988 Apr;26(2):115-9 [3163490.001]
  • [Cites] Rhinology. 2004 Sep;42(3):171-4 [15521673.001]
  • [Cites] Int J Oral Maxillofac Surg. 2006 Jan;35(1):60-6 [15876525.001]
  • [Cites] Rinsho Ketsueki. 1997 Apr;38(4):336-41 [9146064.001]
  • [Cites] Chang Gung Med J. 2002 Jan;25(1):1-8 [11926581.001]
  • [Cites] Indian J Dent Res. 2004 Jul-Sep;15(3):110-3 [15915634.001]
  • [Cites] J Laryngol Otol. 1983 Jul;97(7):657-60 [6875368.001]
  • [Cites] East Afr Med J. 2005 Sep;82(9 Suppl):S135-43 [16619689.001]
  • [Cites] Acta Otolaryngol. 2006 Mar;126(3):277-81 [16618654.001]
  • [Cites] J Indian Soc Pedod Prev Dent. 2001 Dec;19(4):157-9 [12396094.001]
  • [Cites] J Otolaryngol. 1980 Aug;9(4):361-3 [7420527.001]
  • [Cites] J Oral Maxillofac Surg. 1997 Nov;55(11):1212-6 [9371109.001]
  • [Cites] SADJ. 2001 Nov;56(11):524-7 [11885430.001]
  • [Cites] Br Dent J. 1990 Feb 10;168(3):112-5 [2306394.001]
  • [Cites] Laryngorhinootologie. 2004 May;83(5):308-16 [15143448.001]
  • [Cites] J Craniomaxillofac Surg. 1989 Nov;17(8):345-9 [2592574.001]
  • [Cites] Acta Otolaryngol Suppl. 2002;(547):75-8 [12212601.001]
  • [Cites] Bildgebung. 1995 Sep;62(3):199-201 [7496117.001]
  • [Cites] Dtsch Z Mund Kiefer Gesichtschir. 1990 Mar-Apr;14(2):122-31 [2102413.001]
  • [Cites] J Oral Pathol Med. 2003 Sep;32(8):496-8 [12901733.001]
  • [Cites] J Otolaryngol. 1999 Apr;28(2):90-4 [10212875.001]
  • [Cites] J Craniomaxillofac Surg. 1989 Nov;17(8):359-62 [2687333.001]
  • [Cites] Br J Plast Surg. 1998 Dec;51(8):584-8 [10209459.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2000 May 30;52(3):283-6 [10841959.001]
  • (PMID = 17611767.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


14. Usunova I, Vladimirov V: [Benign neoplasms of female urethra]. Akush Ginekol (Sofiia); 2009;48(1):31-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign neoplasms of female urethra].
  • In clinical practice neoplasms of female urethra are found usually in adult women.
  • Histological sample analysis has provided diagnosis of urethral polyp, caruncle and mucosal prolaps.
  • Collaboration between urologists and gynecologists is essential for early diagnosis, prophylaxis and successful treatment of above mentioned diseases.
  • [MeSH-major] Urethral Neoplasms / diagnosis. Urethral Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19496462.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


15. Chekrine T, Tawfiq N, Bourhaleb Z, Benchakroun N, Jouhadi H, Sahraoui S, Benider A: [Giant-cell bone tumors of the spine: report of two cases and literature review]. Cancer Radiother; 2009 Sep;13(5):451-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant-cell bone tumors of the spine: report of two cases and literature review].
  • [Transliterated title] Deux cas de tumeurs osseuses à cellules géantes du rachis et revue de la littérature.
  • Giant cell tumours (GCT) are relatively rare neoplasms, most often benign.
  • We report two observations of GCT, the spine in a 51-year-old woman and a 14-year-old boy.
  • Computed tomography and magnetic resonance imaging showed osteolysis of the body and vertebral arch of L5 for the first and a process affecting the vertebral body and medullary canal of T6-T7 with spinal cord compression for the second case.
  • The diagnosis was confirmed by histological examination in two cases.
  • [MeSH-major] Giant Cell Tumor of Bone / radiotherapy. Spinal Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19615930.001).
  • [ISSN] 1769-6658
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 15
  •  go-up   go-down


16. Munir N, Bradley PJ: Diagnosis and management of neoplastic lesions of the submandibular triangle. Oral Oncol; 2008 Mar;44(3):251-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of neoplastic lesions of the submandibular triangle.
  • Review of submandibular triangle neoplasms (benign and malignant) treated at a tertiary referral centre in the United Kingdom (1986-2004).
  • Forty nine benign and 58 malignant neoplasms of the submandibular triangle were reviewed.
  • Definitive diagnosis was by excision and pathological examination.
  • Pleomorphic adenoma (n=37) were the most common benign neoplasms.
  • The most frequent primary lesions were malignant non-Hodgkin lymphoma (n=22), adenoid cystic carcinoma (n=9) and mucoepidermoid carcinoma (n=9).
  • The mainstay treatment for both benign and malignant lesions was surgical either by extracapsular excision of the gland/lesion or selective levels I, IIa and III neck dissection.
  • Submandibular triangle neoplasms are rare and pose many diagnostic and therapeutic challenges.
  • There is a relatively high incidence of malignant neoplasms in this region (54%).
  • Benign tumours manifest a mild course of disease and have an excellent prognosis following adequate excision.
  • Malignant tumours have a poor symptomatology that can result in late (often post-operative) diagnosis.
  • The adequacy of primary surgery is crucial and would support the approach of a more radical excision primarily with a selective levels I, IIa and III neck dissection; ensuring a definitive operation for benign lesions, avoiding the risks of tumour spillage associated with a more limited excision; and removing the primary echelon of lymph nodes at risk of metastasis if the pathology in fact turns out to be malignant; without a significantly higher morbidity in comparison with an extracapsular gland/lesion excision.
  • [MeSH-major] Mouth Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / surgery. Adenoma, Pleomorphic / diagnosis. Adenoma, Pleomorphic / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / surgery. Child. Female. Humans. Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / surgery. Male. Middle Aged. Retrospective Studies. Submandibular Gland Neoplasms / diagnosis. Submandibular Gland Neoplasms / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17467329.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. Capovilla M, Couturier J, Molinié V, Bruneval P, Vieillefond A: [Juxtaglomerular cell tumors: report of two cases with genomic analysis]. Ann Pathol; 2008 Oct;28(5):474-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Juxtaglomerular cell tumors: report of two cases with genomic analysis].
  • [Transliterated title] Tumeur à rénine du rein : à propos de deux cas, avec analyse génomique.
  • Juxtaglomerular-cell tumor (JGCT), first described in 1967, is a rare tumor of the kidney that derives from specialized smooth-muscle cells of the wall of the glomerular afferent arteriole.
  • JGCTs are considered benign, but the clinical follow-up has been short in most reported cases.
  • Only one metastatic case has been reported to date, raising the question of tumors of uncertain malignant potential rather than clearly benign neoplasms.
  • Similarly to the two previously reported cases, these two tumors showed losses on chromosomes 9 and 11, suggesting recurrent chromosomal imbalances.
  • Thus, JGCT might be better considered as a tumor of uncertain malignant potential consequently requiring a prolonged follow-up.
  • [MeSH-major] Juxtaglomerular Apparatus / pathology. Kidney Cortex / pathology. Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19068398.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


18. Bisdas S, Baghi M, Wagenblast J, Knecht R, Thng CH, Koh TS, Vogl TJ: Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol; 2007 Nov;64(2):258-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results.
  • AIM: We evaluated the feasibility of perfusion CT (CTP) of the parotid gland and attempted to differentiate benign from malignant tumors.
  • MATERIALS AND METHODS: CTP was performed in 17 patients with benign tumors and 10 patients with malignant parotid tumors.
  • Regions of interest were placed through the tumor site and the contralateral healthy parotid tissue.
  • Ratios of the perfusion values between the tumors and the contralateral healthy structures were also calculated.
  • RESULTS: Perfusion maps of all tumors were successfully obtained.
  • High Pearson correlation coefficients comparing the two readers' visually measured abnormalities were observed (r=0.79-0.86, P=0.001) for all perfusion maps, The MTT and PS values between malignant and benign tumors were not significantly different.
  • The BF and BV values were statistically significant different between the benign and malignant tumors (0.00<P<0.02).
  • Only the BV ratio criterion between malignant and benign neoplasms was statistically significant (P<0.004).
  • CONCLUSIONS: CTP of the parotid gland is feasible and may differentiate malignant from non-malignant lesions by means of absolute BF, BV and BV ratio values.
  • [MeSH-major] Image Processing, Computer-Assisted / methods. Parotid Neoplasms / radiography. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adenocarcinoma / radiography. Adenolymphoma / radiography. Adenoma, Pleomorphic / radiography. Aged. Blood Volume / physiology. Capillary Permeability / physiology. Carcinoma, Adenoid Cystic / radiography. Contrast Media. Diagnosis, Differential. Feasibility Studies. Female. Humans. Iopamidol / analogs & derivatives. Male. Middle Aged. Parotid Gland / blood supply. Parotid Gland / radiography. Radiographic Image Enhancement / methods. Regional Blood Flow / physiology. Time Factors

  • MedlinePlus Health Information. consumer health - CT Scans.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17399933.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media; 17E17JBP8L / iomeprol; JR13W81H44 / Iopamidol
  •  go-up   go-down


19. Duerr EM, Mizukami Y, Ng A, Xavier RJ, Kikuchi H, Deshpande V, Warshaw AL, Glickman J, Kulke MH, Chung DC: Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer; 2008 Mar;15(1):243-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
  • Current classifications of human gastroenteropancreatic neuroendocrine tumors (NETs) are inconsistent and based upon histopathologic but not molecular features.
  • We sought to compare a molecular classification with the World Health Organization (WHO) histologic classification, identify genes that may be important for tumor progression, and determine whether gastrointestinal NETs (GI-NETs) differ in their molecular profile from pancreatic NETs (PNETs).
  • DNA microarray analysis was performed to identify differentially expressed genes in PNETs and GI-NETs.
  • Hierarchical clustering of 19 PNETs revealed a 'benign' and 'malignant' cluster that corresponded well with the WHO categories of well-differentiated endocrine tumor (WDET) and well-differentiated endocrine carcinoma (WDEC) respectively.
  • Malignant ileal GI-NETs exhibited a distinctive gene expression profile, and extracellular matrix protein 1 (ECM), vesicular monoamine member 1 (VMAT1), galectin 4 (LGALS4), and RET Proto-oncogene (RET) were highly up-regulated genes.
  • Gene expression profiles reflect the current WHO classification and can distinguish benign from malignant PNETs and also PNETs from GI-NETs.
  • This suggests that molecular profiling may enhance tumor classification schemes.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18310291.001).
  • [ISSN] 1351-0088
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK040561; None / None / / P30 DK040561-12; United States / NIDDK NIH HHS / DK / P30 DK040561-12
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


20. Yates CW, Weinberg M, Packer MJ, Jacob A: Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma. Ann Otol Rhinol Laryngol; 2010 Jun;119(6):402-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma.
  • Vestibular schwannomas are benign neoplasms that arise from Schwann cells of the eighth cranial nerve.
  • We report the case of a 69-year-old man with a large vestibular schwannoma who required anticoagulation for several medical comorbidities.
  • Attempts were made to stabilize the patient, including posterior fossa craniectomy and evacuation of hematoma; however, the intracranial hemorrhage ultimately resulted in a fatal outcome.
  • During this procedure, a biopsy specimen was obtained, showing benign vestibular schwannoma.

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. WARFARIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20583739.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  •  go-up   go-down


21. Spalding DR, Isla AM, Thompson JN, Williamson RC: Pancreas-sparing distal duodenectomy for infrapapillary neoplasms. Ann R Coll Surg Engl; 2007 Mar;89(2):130-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreas-sparing distal duodenectomy for infrapapillary neoplasms.
  • INTRODUCTION: For neoplasms that arise in the third and fourth parts of the duodenum (D(3), D(4)), a duodenectomy that preserves the pancreas can provide adequate tumour clearance while avoiding the additional dissection and risk of the common alternative, pancreatoduodenectomy.
  • PATIENTS AND METHODS: Pancreas-sparing distal duodenectomy (PSDD) was performed in 14 patients with infrapapillary duodenal neoplasms between 1991-2002, and the clinical outcome is reviewed.
  • There were 11 malignant neoplasms (adenocarcinoma 5, stromal tumour 4, recurrent seminoma 1, plasmacytoma 1), 2 benign neoplasms (villous adenoma, lipoma) and 1 patient with steroid-induced ulceration.
  • Median operation time was 240 min and median blood loss 1197 ml, being greater for malignant than benign lesions (1500 ml versus 700 ml).
  • At a median follow-up of 47 months, three patients had died of recurrent disease while the other 10 were alive and well with no upper gastrointestinal symptoms.
  • CONCLUSIONS: Provided there is a minimum 1-cm clearance at the papilla, PSDD is a useful alternative to formal pancreatoduodenectomy in patients with unusual neoplasms arising from the third and fourth parts of the duodenum.
  • Although a major undertaking in its own right, it avoids the extra time of a pancreatic resection and the extra risk of a pancreatic anastomosis.
  • [MeSH-major] Adenocarcinoma, Papillary / surgery. Duodenal Neoplasms / surgery. Pancreas / surgery. Pancreaticoduodenectomy / methods

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1999 Dec;42(12):1533-6 [10613470.001]
  • [Cites] Hepatogastroenterology. 1999 May-Jun;46(27):1953-8 [10430376.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 1999;6(4):414-7 [10664293.001]
  • [Cites] Dig Surg. 2000;17(4):410-2 [11053954.001]
  • [Cites] Ned Tijdschr Geneeskd. 2002 Mar 30;146(13):621-4 [11957383.001]
  • [Cites] Arch Surg. 2002 May;137(5):557-62; discussion 562-3 [11982469.001]
  • [Cites] J Gastrointest Surg. 2002 Jan-Feb;6(1):82-7 [11986022.001]
  • [Cites] Eur J Surg. 2002;168(2):74-7 [12113274.001]
  • [Cites] Surg Endosc. 2002 Sep;16(9):1362-3 [12072993.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(3):393-6 [12353155.001]
  • [Cites] Hepatogastroenterology. 2003 May-Jun;50(51):711-3 [12828067.001]
  • [Cites] Hepatogastroenterology. 2004 May-Jun;51(57):727-31 [15143902.001]
  • [Cites] Surg Gynecol Obstet. 1976 Jun;142(6):858-60 [936029.001]
  • [Cites] Am J Proctol Gastroenterol Colon Rectal Surg. 1981 Aug;32(8):18-21, 28 [7027808.001]
  • [Cites] Ann Surg. 1983 Feb;197(2):172-8 [6337568.001]
  • [Cites] Cancer. 1985 Nov 1;56(9):2242-50 [4052969.001]
  • [Cites] World J Surg. 1985 Dec;9(6):914-20 [4082613.001]
  • [Cites] Ann Surg. 1986 Mar;203(3):301-6 [3954483.001]
  • [Cites] Am J Surg. 1987 Apr;153(4):350-4 [3565678.001]
  • [Cites] Br J Surg. 1988 Feb;75(2):184-6 [3349313.001]
  • [Cites] Ann Surg. 1989 May;209(5):593-8; discussion 598-9 [2650645.001]
  • [Cites] Ann Surg. 1989 Oct;210(4):544-54; discussion 554-6 [2679459.001]
  • [Cites] Arch Surg. 1990 Aug;125(8):961-5 [2378560.001]
  • [Cites] Arch Surg. 1992 Aug;127(8):945-9; discussion 949-50 [1353671.001]
  • [Cites] Ann Surg. 1993 May;217(5):430-5; discussion 435-8 [8098202.001]
  • [Cites] Br J Surg. 1994 Oct;81(10):1472-4 [7820475.001]
  • [Cites] J Surg Oncol. 1995 Jan;58(1):70-3 [7823577.001]
  • [Cites] Surgery. 1995 Mar;117(3):254-9 [7878529.001]
  • [Cites] Ann R Coll Surg Engl. 1994 Nov;76(6):403-4 [7702324.001]
  • [Cites] Jpn J Clin Oncol. 1995 Jun;25(3):109-12 [7596048.001]
  • [Cites] Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92 [7574936.001]
  • [Cites] Am J Surg. 1996 Jan;171(1):62-7 [8554153.001]
  • [Cites] Hepatogastroenterology. 1996 Jul-Aug;43(10):835-8 [8884299.001]
  • [Cites] Gastroenterology. 1997 Sep;113(3):983-94 [9287993.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):248-57; discussion 257-60 [9339931.001]
  • [Cites] J Gastrointest Surg. 1998 Jan-Feb;2(1):79-87 [9841972.001]
  • [Cites] Dig Surg. 1998;15(5):398-403 [9845621.001]
  • [Cites] Dig Surg. 1999;16(1):22-5 [9949263.001]
  • [Cites] J Gastrointest Surg. 2000 Jan-Feb;4(1):13-21, discussion 22-3 [10631358.001]
  • (PMID = 17346405.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1964558
  •  go-up   go-down


22. Brønden LB, Eriksen T, Kristensen AT: Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry. Acta Vet Scand; 2009;51:54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry.
  • Neoplasms originating in the head and neck region are a heterogeneous group.
  • Also the proportions of benign and malignant neoplasms of different locations in dogs were compared using Fisher's exact test.
  • RESULTS: A total of 1768 cases of neoplasias (679 malignant, 826 benign, 263 unknown) were submitted.
  • Of all neoplasias HNC accounted for 7.2% (n = 128).
  • Of these, 64 (50%) were malignant and 44 (34%) benign.
  • The most common types of malignant neoplasia were SCC (18; 28% of malignant), OMM (13; 20% of malignant), soft tissue sarcoma (11; 17% of malignant) and adenocarcinoma (5; 11% of malignant).
  • The most common types of benign neoplasms were adenoma (7; 16% of benign), polyps (6; 14% of benign) and fibroma (5; 11% of benign).
  • CONCLUSIONS: In the current study, the proportion of neoplasia in the head and neck region in dogs in Denmark was similar to other canine studies and significantly more common than in humans with a large proportion of malignancies.
  • [MeSH-major] Dog Diseases / epidemiology. Head and Neck Neoplasms / veterinary. Melanoma / veterinary. Mouth Neoplasms / veterinary. Registries

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vet Pathol. 2000 Nov;37(6):597-608 [11105949.001]
  • [Cites] Vet Comp Oncol. 2009 Sep;7(3):207-11 [19691649.001]
  • [Cites] Lancet Oncol. 2001 Apr;2(4):205-11 [11905765.001]
  • [Cites] Prev Vet Med. 2003 Apr 30;58(1-2):63-74 [12628771.001]
  • [Cites] Clin Cancer Res. 2003 Apr;9(4):1284-90 [12684396.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Oct;61(10):1132-9 [14586846.001]
  • [Cites] J Natl Cancer Inst. 1968 Feb;40(2):307-18 [5694272.001]
  • [Cites] Arch Environ Health. 1971 Jan;22(1):136-40 [4322006.001]
  • [Cites] Eur J Cancer. 1978 Dec;14(12):1299-308 [367792.001]
  • [Cites] Vet Hum Toxicol. 1979 Aug;21(4):277-84 [91256.001]
  • [Cites] Am J Epidemiol. 1981 Aug;114(2):229-33 [7304557.001]
  • [Cites] Onderstepoort J Vet Res. 1983 Sep;50(3):199-220 [6646663.001]
  • [Cites] Vet Rec. 1984 Apr 7;114(14):341-2 [6719788.001]
  • [Cites] Acta Vet Scand Suppl. 1988;84:290-2 [3232625.001]
  • [Cites] J Toxicol Environ Health. 1989;28(4):407-14 [2593174.001]
  • [Cites] Cancer Metastasis Rev. 1990 Sep;9(2):125-36 [2253312.001]
  • [Cites] Am J Epidemiol. 1992 Feb 1;135(3):234-9 [1546698.001]
  • [Cites] Zentralbl Veterinarmed A. 1992 Jun;39(5):328-41 [1496862.001]
  • [Cites] Tidsskr Nor Laegeforen. 1995 Feb 28;115(6):714-7 [7900133.001]
  • [Cites] Berl Munch Tierarztl Wochenschr. 1996 Aug;109(8):292-303 [9005839.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 1997 Jan;27(1):101-13 [9002170.001]
  • [Cites] Mol Med Today. 1997 Jan;3(1):8-11 [9021736.001]
  • [Cites] Vet Rec. 1997 Jul 12;141(2):40-4 [9253830.001]
  • [Cites] Am J Epidemiol. 1998 Mar 1;147(5):488-92 [9525536.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1998 Sep;124(9):951-62 [9738803.001]
  • [Cites] Int J Cancer. 2005 May 1;114(5):806-16 [15609302.001]
  • [Cites] Vaccine. 2006 May 22;24(21):4582-5 [16188351.001]
  • [Cites] Oral Oncol. 2007 Feb;43(2):116-21 [16931116.001]
  • [Cites] Alcohol Res Health. 2006;29(3):193-8 [17373408.001]
  • [Cites] Clin Tech Small Anim Pract. 2007 May;22(2):55-60 [17591290.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 2007 Nov;37(6):1111-9; vi-ii [17950885.001]
  • [Cites] Can Vet J. 2008 Jan;49(1):71-6 [18320982.001]
  • [Cites] Can Vet J. 2008 May;49(5):509-12 [18512465.001]
  • [Cites] Eur J Cancer Prev. 2008 Aug;17(4):340-4 [18562959.001]
  • [Cites] J Vet Intern Med. 2008 Jul-Aug;22(4):976-84 [18564221.001]
  • [Cites] Head Neck. 2008 Dec;30(12):1543-51 [18704960.001]
  • [Cites] Clin Cancer Res. 2009 Feb 15;15(4):1443-51 [19228745.001]
  • [Cites] Oral Oncol. 2009 Mar;45(3):254-8 [18675580.001]
  • [Cites] Cancer Invest. 2000;18(8):781-92 [11107448.001]
  • (PMID = 20021647.001).
  • [ISSN] 1751-0147
  • [Journal-full-title] Acta veterinaria Scandinavica
  • [ISO-abbreviation] Acta Vet. Scand.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2803174
  •  go-up   go-down


23. Arai E, Nishida Y, Tsukushi S, Sugiura H, Ishiguro N: Intramuscular granular cell tumor in the lower extremities. Clin Orthop Relat Res; 2010 May;468(5):1384-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intramuscular granular cell tumor in the lower extremities.
  • Granular cell tumors are uncommon but typically histologically benign neoplasms that occasionally behave as malignant tumors.
  • Differentiation of benign granular cell tumors from malignant counterparts with radiographic and/or histologic analysis is crucial for physicians.
  • We retrospectively studied five cases of intramuscular granular cell tumors arising in the lower extremities.
  • All tumors had been histologically diagnosed as benign and were resected with a wide surgical margin.
  • Intramuscular granular cell tumors can be diagnosed based on their characteristic MRI features, such as peripheral high intensity on T2-weighed images, and histologic evaluation.
  • The histologic criteria described by Fanburg-Smith et al. can differentiate malignant granular cell tumors from benign tumors.
  • A wide resection seems suitable for most granular cell tumors in the extremities.
  • [MeSH-major] Granular Cell Tumor / diagnosis. Leg
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Prognosis. Retrospective Studies. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2000 Nov;(380):191-8 [11064991.001]
  • [Cites] Cancer. 2001 Dec 25;93(6):398-408 [11748580.001]
  • [Cites] Bull Hosp Joint Dis. 1975 Oct;36(2):121-9 [1218280.001]
  • [Cites] Am Surg. 1987 Mar;53(3):156-60 [3030172.001]
  • [Cites] Cancer. 1990 Feb 15;65(4):897-900 [2404563.001]
  • [Cites] Neurosurg Focus. 2007;22(6):E25 [17613217.001]
  • [Cites] Am J Surg Pathol. 1998 Jul;22(7):779-94 [9669341.001]
  • [Cites] Histopathology. 2005 Aug;47(2):179-85 [16045779.001]
  • [Cites] Skeletal Radiol. 2005 Oct;34(10):625-31 [16003548.001]
  • [Cites] Clin Orthop Relat Res. 2007 Feb;455:267-73 [16936589.001]
  • [Cites] Skeletal Radiol. 1997 Feb;26(2):116-21 [9060104.001]
  • (PMID = 19760336.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2853648
  •  go-up   go-down


24. Russo A, Zaottini A: [Diagnosis of synovial sarcoma of the knee accidentally revealed by trauma. Role of ultrasound. Differential diagnosis by scar-hematoma]. Ann Ital Chir; 2009 Mar-Apr;80(2):151-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis of synovial sarcoma of the knee accidentally revealed by trauma. Role of ultrasound. Differential diagnosis by scar-hematoma].
  • [Transliterated title] Diagnosi di sarcoma sinoviale del ginocchio fortuitamente favorita da evento traumatico. Il contributo dell'ecografia in urgenza al sospetto clinico e la diagnosi differenziale con l'ematoma in fase di cicatrizzazione.
  • Generally arising in the contest of joint or from immediately surrounding anatomical sites, first of all affecting inferior limbs (2/3), a sarcoma of the knee, elective anatomical site, is described, accidentally diagnosed after traumatic event.
  • Exhibiting a very poor 5 year survey, (55%), related to dimension, distal or proximal arising, necrosis rate and grading, it's the most fequently soft tissue malignancy misdiagnosed with benign neoplasms, such as Baker cyst or villonodular pigmented synovitis, considering its deceiving macroscopic and chronological features; the differential diagnosis seems to be very hard, relying on histhological biopsy.
  • [MeSH-major] Cicatrix, Hypertrophic / ultrasonography. Hematoma / ultrasonography. Knee Injuries / ultrasonography. Knee Joint / ultrasonography. Sarcoma, Synovial / ultrasonography. Soft Tissue Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Incidental Findings. Male. Middle Aged. Prognosis. Treatment Outcome

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • MedlinePlus Health Information. consumer health - Knee Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19681299.001).
  • [ISSN] 0003-469X
  • [Journal-full-title] Annali italiani di chirurgia
  • [ISO-abbreviation] Ann Ital Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


25. Naama O, Gazzaz M, Akhaddar A, Belhachmi A, Asri A, Elmostarchid B, Elbouzidi A, Kadiri B, Boucetta M: Cavernous hemangioma of the skull: 3 case reports. Surg Neurol; 2008 Dec;70(6):654-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Intraosseous cavernous hemangiomas of the bone are uncommon tumors, accounting for 0.7% to 1% of all bone neoplasms.
  • Calvarial cavernous hemangioma is rare, comprising about 0.2% of all benign neoplasms of the skull.
  • CONCLUSION: Skull cavernous hemangiomas are rare benign tumors.
  • The preferred treatment is complete tumor removal with normal bony margins.
  • Consequently, the diagnosis is most often made during surgical resection.
  • [MeSH-major] Hemangioma, Cavernous / pathology. Skull Neoplasms / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207223.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Santos RR, Damasceno RW, de Pontes FS, Cursino SR, Nishiwaki-Dantas MC, Vital Filho J, Dantas PE: Ten-year follow-up of a case series of primary epithelial neoplasms of the lacrimal gland: clinical features, surgical treatment and histopathological findings. Arq Bras Oftalmol; 2010 Jan-Feb;73(1):33-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ten-year follow-up of a case series of primary epithelial neoplasms of the lacrimal gland: clinical features, surgical treatment and histopathological findings.
  • PURPOSE: To describe and analyze the features of a cases series of patients with primary epithelial neoplasms of the lacrimal gland, its surgical treatment, and histopathological findings.
  • METHODS: Retrospective evaluation of files from patients with primary epithelial neoplasms of the lacrimal gland in the period from 1997 to 2007.
  • All patients with primary epithelial tumors of the lacrimal gland were included in this study.
  • The slides with histological sections of the tumors were reviewed by the same pathologist.
  • RESULTS: During the study period, there were 12 patients, 5 (41.7%) with benign tumors, all pleomorphic adenomas (benign mixed tumor) and 7 (58.3%) with malignant neoplasms, thus distributed: four cases of adenoid cystic carcinoma, two of mucoepidermoid carcinoma and one carcinoma expleomorphic adenoma.
  • Globally, patients mean age was 54.1 years-old (ranging from 14 to 70 years-old), with mean age of 52.4 years-old (ranging from 14 to 65 years-old) for benign neoplasms, and 55.3 years-old for malignant neoplasms (ranging from 26 to 70 years-old).
  • CONCLUSIONS: The most frequent primary epithelial neoplasms of the lacrimal gland were pleomorphic adenoma and adenoid cystic carcinoma during the study period.
  • Malignant tumors were more frequent than benign tumors.
  • The histopathological diagnosis and the disease initial stage can play a significant role in patient's survival.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Young Adult

  • Genetic Alliance. consumer health - TEN.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20464111.001).
  • [ISSN] 1678-2925
  • [Journal-full-title] Arquivos brasileiros de oftalmologia
  • [ISO-abbreviation] Arq Bras Oftalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


27. Tian W, Li X, Li D, Liu X, Lin S, Liang Y: [Imageology features and transoral approach of benign parapharyngeal space tumors]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov;24(21):983-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Imageology features and transoral approach of benign parapharyngeal space tumors].
  • OBJECTIVE: To analyze the imageology features of benign parapharyngeal space (PPS) tumors, and also to summarize our experience in removing PPS benign tumors through transoral approach.
  • METHOD: A retrospective review was conducted to 48 patients with benign tumors in PPS during a 10-year period.
  • RESULT: CT scan and MRI often provided complementary information to help the surgeons delineate the size, precise location and likely cause of these tumors.
  • The transoral approach described herein safely allowed for en bloc resection of most benign neoplasms.
  • CONCLUSION: CT or MRI scan can distinguish prestyloid from poststyloid lesions, and to assess the extension of the tumor as well as its relationship with adjacent structures.
  • The transoral approach safely provides access to some benign PPS tumors with a low rate of complications and recurrence as well as traditional transcervical approaches.
  • [MeSH-major] Neoplasms / diagnosis. Neoplasms / surgery. Pharyngeal Neoplasms / diagnosis. Pharyngeal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21261019.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


28. Meher R, Varshney S: Leiomyoma of the nose. Singapore Med J; 2007 Oct;48(10):e275-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyomas are benign neoplasms that are thought to originate from the vascular smooth muscle.
  • They have a propensity to arise from the gastrointestinal tract, female genital tract (uterus) and subcutaneous tissue.
  • The nasal cavity is an uncommon site for a leiomyoma.
  • [MeSH-major] Leiomyoma / pathology. Nose Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17909665.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


29. Chon SH, Lee CB, Shinn SH, Heo JN, Paik SS: Rib xanthoma resected by video-assisted thoracoscopic surgery using a bone punch. Surg Laparosc Endosc Percutan Tech; 2009 Feb;19(1):e15-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Xanthomas of the rib are extremely rare benign neoplasms, most commonly reported in soft tissue, but rarely in bone.
  • We report a case of a 4-cm xanthoma of the rib resected by video-assisted thoracoscopic surgery and pulled through a 2-cm port incision around the patient's areola.
  • To the best of our knowledge, there are only 8 other such cases, and none of which were removed by thoracoscopic surgery.
  • [MeSH-major] Bone Neoplasms / surgery. Ribs / surgery. Thoracic Surgery, Video-Assisted. Xanthomatosis / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19238049.001).
  • [ISSN] 1534-4908
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Hotakainen K, Tanner P, Alfthan H, Haglund C, Stenman UH: Comparison of three immunoassays for CA 19-9. Clin Chim Acta; 2009 Feb;400(1-2):123-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Carbohydrate antigen (CA) 19-9 is a valuable tumor marker for gastrointestinal (GI) cancers, but results obtained by different assays vary and a change of method during follow-up may cause problems.
  • Between-method correlation was studied in 610 serum samples from patients with GI disease.
  • Clinical performance was compared using samples from 68 patients with benign GI diseases and 106 cancer patients.
  • RESULTS: The Architect assay measured significantly lower concentrations than the other assays in controls and benign disease (p<0.0001), and the upper reference limit was lower (26 kU/l) than for Elecsys (36 kU/l).
  • The area under curve (AUC) for discrimination between benign disease and pancreatic cancer was significantly larger (0.90; 95% CI 0.83-0.98) than for Elecsys (0.78) and Immuno 1 (0.76).
  • However, for all assays a cut-off of 37 kU/l provided optimal separation between benign and malignant disease.
  • CONCLUSIONS: The Architect CA 19-9XR assay measures lower concentrations than the other two assays in benign conditions.
  • Thus it provides the best discrimination between benign and malignant GI disease.
  • [MeSH-major] Antigens, Tumor-Associated, Carbohydrate / analysis. Immunoassay / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19038241.001).
  • [ISSN] 1873-3492
  • [Journal-full-title] Clinica chimica acta; international journal of clinical chemistry
  • [ISO-abbreviation] Clin. Chim. Acta
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antigens, Tumor-Associated, Carbohydrate
  •  go-up   go-down


31. Levy AD, Patel N, Dow N, Abbott RM, Miettinen M, Sobin LH: From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics; 2005 Mar-Apr;25(2):455-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation.
  • Mutations of the NF1 gene lead to abnormal tumor suppression.
  • Consequently, patients with NF1 have an increased prevalence of benign and malignant neoplasms throughout the body.
  • There are five categories of NF1 tumors that occur in the abdomen: neurogenic, neuroendocrine, nonneurogenic gastrointestinal mesenchymal, embryonal, and miscellaneous.
  • Many of these tumors are age related, occur at specific anatomic locations, and have unique imaging features.
  • Notably, many patients have a variety of organs affected because there is a high prevalence of multiple tumors occurring in the same patient.
  • Neurofibromas are the most common benign neoplasms and may occur in the retroperitoneum or visceral organs.
  • Malignant peripheral nerve sheath tumor is an aggressive malignancy that is the most common malignant tumor of the abdomen in patients with NF1.
  • Interpreting abdominal imaging studies in patients with NF1 can be challenging because of the wide spectrum and diverse nature of tumors that occur in this disease.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Neurofibromatosis 1 / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Nerve Sheath Neoplasms / diagnosis. Neuroendocrine Tumors / diagnosis. Neurofibroma / diagnosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • Genetic Alliance. consumer health - Neurofibromatosis type 1.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15798063.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 77
  •  go-up   go-down


32. Silverman SG, Israel GM, Herts BR, Richie JP: Management of the incidental renal mass. Radiology; 2008 Oct;249(1):16-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite substantial advances in the imaging-based diagnosis of renal masses, the increased detection of incidental renal masses with cross-sectional imaging poses problems to the radiologist and referring physician.
  • In this article, the literature will be reviewed and an approach to the diagnosis and management of the incidental renal mass will be suggested.
  • However, additional imaging, and in selected patients, percutaneous biopsy, is recommended to diagnose benign neoplasms.
  • [MeSH-major] Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Comorbidity. Female. Humans. Kidney Diseases, Cystic / classification. Kidney Diseases, Cystic / diagnosis. Kidney Diseases, Cystic / therapy. Life Expectancy. Magnetic Resonance Imaging. Male. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) RSNA, 2008.
  • (PMID = 18796665.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 102
  •  go-up   go-down


33. de Vicente Rodríguez JC, Fresno Forcelledo MF, González García M, Aguilar Andrea C: Sebaceous adenoma of the parotid gland. Med Oral Patol Oral Cir Bucal; 2006 Aug;11(5):E446-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors of the salivary glands constitute an important field of oral and maxillofacial pathology.
  • The majority of salivary gland neoplasms are benign, with malignant salivary tumors accounting for 15 to 32 percent.
  • The most common site for salivary gland tumors is the parotid gland, accounting up to 80 percent of all cases.
  • This article reports the pathologic picture in a case of sebaceous adenoma of the parotid gland.
  • The tumor was composed of epithelial cells lining ducts and closely associated with broad areas of sebaceous differentiation.
  • The presence of sebaceous glands in salivary neoplasms is frequent, however, and in spite of this, salivary neoplasms constituted partially or entirely of these cells are rarely observed.
  • To the surgeon and pathologist, the major problem in dealing with sebaceous adenoma is the recognition of this rare entity, avoiding confusing with other more aggressive neoplasms.
  • [MeSH-major] Adenoma / pathology. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16878064.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


34. Radovanović D, Stevanović D, Pavlović I, Jasarović D, Mitrović N, Ilić I: [Gastrointerstinal stromal tumors of the stomach--case reports]. Med Pregl; 2008 Jul-Aug;61(7-8):409-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gastrointerstinal stromal tumors of the stomach--case reports].
  • INTRODUCTION: Gastrointestinal stromal tumors are the most common mesenchimal tumors of the gastrointestinal tract.
  • Despite the enormous progress made in the field of diagnostics, most often diagnosis is made during the explorative laparotomy and postoperative immunohystochemical analysis of specimen.
  • The surgical treatment is often indicated, although scarce preoperative diagnosis causes intraoperative dilemma concerning the level of radicality.
  • Intraoperatively besides the transverse colon cancer, we found intramural gastric tumor.
  • The immunohystochemical analysis of gastric tumor proves benign GIST.
  • The second patient was 50 year old male presented with repeated upper GI bleeding.
  • The endoscopic ultrasound showed intramural tumor of the anterior gastric wall, with a visible blood vessel bleeding during endoscopy.
  • DISCUSSION: In the cases with inadequate preoperative diagnoses, the level of resection procedure is based on the size of tumor and the presence of necrosis and bleeding inside the tumor.
  • Tumors larger than 5 cm in diameter with signs of necrosis and bleeding are parameters of malignant nature of GIST, therefore demanding a radical surgical treatment.
  • CONCLUSION: The surgical resection is a treatment of choice for gastrointestinal stromal tumors.
  • [MeSH-major] Gastrointestinal Stromal Tumors. Stomach Neoplasms

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19097381.001).
  • [ISSN] 0025-8105
  • [Journal-full-title] Medicinski pregled
  • [ISO-abbreviation] Med. Pregl.
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


35. Shetty C, Avinash KR, Auluck A: Schwannoma of vagus nerve masquerading as a parotid tumour. Dentomaxillofac Radiol; 2006 Sep;35(5):376-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Schwannoma of vagus nerve masquerading as a parotid tumour.
  • A post-auricular swelling is the most common presentation of a parotid tumour, the majority of which are benign neoplasms like pleomorphic adenoma.
  • This case report discusses a post-styloid parapharyngeal space tumour presenting as a post-auricular mass which, on initial clinical and cytological examination, was diagnosed as pleomorphic adenoma.
  • A radiological differential diagnosis is also discussed.
  • [MeSH-major] Cranial Nerve Neoplasms / radiography. Neurilemmoma / radiography. Vagus Nerve Diseases / radiography
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Parotid Neoplasms / diagnosis. Pharynx / radiography. Tomography, Spiral Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16940487.001).
  • [ISSN] 0250-832X
  • [Journal-full-title] Dento maxillo facial radiology
  • [ISO-abbreviation] Dentomaxillofac Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


36. Seseke S, Schweyer S, Reissig K, Seseke F: [Leiomyoma of the urethra - cause of an obstruction misdiagnosed as hereditary urethral stricture in a young man]. Aktuelle Urol; 2008 Mar;39(2):150-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Leiomyoma of the urethra - cause of an obstruction misdiagnosed as hereditary urethral stricture in a young man].
  • Leiomyomas are benign neoplasms arising from smooth muscle cells.
  • We describe the case of a 17-year-old boy admitted with progressive severe obstructive voiding symptoms.
  • Histopathological examination confirmed the very rare case of a leiomyoma of the urethra.
  • [MeSH-major] Leiomyoma / complications. Urethral Neoplasms / complications. Urethral Stricture / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18379970.001).
  • [ISSN] 0001-7868
  • [Journal-full-title] Aktuelle Urologie
  • [ISO-abbreviation] Aktuelle Urol
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


37. Salles VJ, Marotta A, Netto JM, Speranzini MB, Martins MR: Bile duct hamartomas--the von Meyenburg complex. Hepatobiliary Pancreat Dis Int; 2007 Feb;6(1):108-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hamartomas of the bile duct (von Meyenburg complex) are benign neoplasms of the liver, constituted histologically cystic dilatations of the bile duct, encompassed by fibrous stroma.
  • Magnetic resonance imaging and liver biopsy are the gold standards for diagnosis of this rare hepatobiliary condition.

  • MedlinePlus Health Information. consumer health - Bile Duct Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17287178.001).
  • [ISSN] 1499-3872
  • [Journal-full-title] Hepatobiliary & pancreatic diseases international : HBPD INT
  • [ISO-abbreviation] HBPD INT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


38. Wüstenberg EG, Offergeld C, Zahnert T, Hüttenbrink KB, Kittner T: Extension of intracranial thrombosis after unilateral dissection of the internal jugular vein. Arch Otolaryngol Head Neck Surg; 2005 May;131(5):430-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Resection of the internal jugular vein can be necessary in cases of radical neck dissection or even in cases involving benign neoplasms such as glomus tumors.
  • According to the triad described by Virchow (ie, stasis of blood flow, damage to the endothelium, and changes in hemostasis), the development of a thrombosis in the venous vessels superior to the resected internal jugular vein seems to be possible.
  • Sixteen patients had malignant tumors, and 1 patient had a glomus tumor.
  • After unilateral radical neck dissection, the venous blood leaves the brain mainly via the venous system of the other side of the neck and the ipsilateral collateral veins.

  • Genetic Alliance. consumer health - Thrombosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15897422.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Radlinsky MG: Thyroid surgery in dogs and cats. Vet Clin North Am Small Anim Pract; 2007 Jul;37(4):789-98, viii
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thyroid surgery is indicated for malignant and benign neoplasms or hyperplasia of the thyroid glands.

  • MedlinePlus Health Information. consumer health - Thyroid Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17619012.001).
  • [ISSN] 0195-5616
  • [Journal-full-title] The Veterinary clinics of North America. Small animal practice
  • [ISO-abbreviation] Vet. Clin. North Am. Small Anim. Pract.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


40. Mascarenhas F, Costa MS, Ortiz M, Almeida A, Carvalho H, Ferreira AG, Cattoni MB: [Stereotactic radiosurgery in the intracranial benign neoplasms and malignant tumors of the brain]. Acta Med Port; 2005 Jan-Feb;18(1):45-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Stereotactic radiosurgery in the intracranial benign neoplasms and malignant tumors of the brain].
  • Stereotactic Radiosurgery has proven to be during the last years the therapy of choice in more and more patients with benign and malignant brain tumors.
  • This series presents the experience of treating more than 100 intracranial lesions with linear accelerator-based radiosurgery at Hospital de Santa Maria in Lisbon with special emphasis on the indications and results.
  • It also provides a review of the concepts and procedures of this modality as well as a general overview of the main published results in series of patients with brain tumors treated with stereotactic radiosurgery.
  • [MeSH-major] Brain Neoplasms / surgery. Radiosurgery

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16202334.001).
  • [ISSN] 1646-0758
  • [Journal-full-title] Acta médica portuguesa
  • [ISO-abbreviation] Acta Med Port
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Portugal
  •  go-up   go-down


41. Dhingra KK, Setia N, Khurana N: A rare case of congenital nasopharyngeal teratoma presenting with respiratory distress. Indian J Otolaryngol Head Neck Surg; 2010 Sep;62(3):329-31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Teratomas of the head and neck are rare, benign neoplasms, usually presenting in the neonatal period and are often malignant with regard to their location.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr Surg. 1987 Feb;22(2):179-81 [3820022.001]
  • [Cites] Otolaryngol Head Neck Surg (1979). 1980 May-Jun;88(3):221-6 [7402661.001]
  • [Cites] Ultrasound Obstet Gynecol. 1999 Apr;13(4):271-3 [10341408.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Dec;94(6):741-5 [12464901.001]
  • [Cites] Am J Otolaryngol. 2007 May-Jun;28(3):177-9 [17499134.001]
  • (PMID = 23120736.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450234
  • [Keywords] NOTNLM ; Congenital / Nasopharyngeal / Teratoma
  •  go-up   go-down


42. Velusamy A, Saw S, Gossage J, Bailey S, Schofield J: Combined adenocarcinoid and mucinous cystadenoma of the appendix: a case report. J Med Case Rep; 2009;3:28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Adenocarcinoid of the appendix is a rare malignant tumour with features of both adenocarcinoma and carcinoid, showing both epithelial and endocrine differentiation.
  • Mucinous cystadenoma is the commonest of the benign neoplasms of the appendix, with an incidence of 0.6% in appendicectomy specimens.
  • Right hemicolectomy is generally advised if any of the following features are present: tumours greater than 2 cm, involvement of resection margins, greater than 2 mitoses/10 high-power fields on histology, extension of tumour beyond serosa.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Tumori. 2007 Nov-Dec;93(6):587-90 [18338494.001]
  • [Cites] Histopathology. 2007 Dec;51(6):763-73 [18042066.001]
  • [Cites] Endocr Pathol. 2007 Spring;18(1):16-22 [17652796.001]
  • [Cites] J Gastroenterol. 2006 Aug;41(8):745-9 [16988762.001]
  • [Cites] Ann Surg. 2006 Jul;244(1):52-60 [16794389.001]
  • [Cites] Arch Pathol Lab Med. 2001 Mar;125(3):386-90 [11231488.001]
  • [Cites] Histopathology. 1995 Dec;27(6):557-62 [8838336.001]
  • [Cites] J Clin Pathol. 1995 Sep;48(9):869-70 [7490325.001]
  • [Cites] Cancer. 1974 Aug;34(2):338-44 [4852178.001]
  • [Cites] Am Surg. 2004 Jul;70(7):593-9 [15279181.001]
  • [Cites] World J Surg. 2005 Nov;29(11):1436-9 [16136284.001]
  • (PMID = 19171048.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2647933
  •  go-up   go-down


43. Garrido-Ruiz MC, Carrillo R, Enguita AB, Peralto JL: Signet-ring cell dermatofibroma. Am J Dermatopathol; 2009 Feb;31(1):84-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dermatofibroma or cutaneous fibrous histiocytoma is a common benign skin lesion with multiple, distinct histologic variants, including cellular, aneurismal, epithelioid, atypical, lipidized "ankle-type," palisading, and cholesterotic.
  • Although dermatofibromas are considered benign neoplasms, certain variants including cellular and aneurismal ones have shown to have a notable tendency to locally recur after excision.
  • The finding of signet-ring cells in a skin neoplasm always raises the suspicion of metastatic adenocarcinoma, although a number of reports have shown their occurrence in primitive cutaneous neoplasms as well.
  • We present, for the first time, a new, distinctive variant of dermatofibroma, so-called signet-ring cell dermatofibroma, in a 16-year-old man with a slowly growing skin tumor on the lateral side of his right leg.
  • Histochemical and immunohistochemical stainings confirmed the diagnosis of dermatofibroma.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Dermatofibroma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19155733.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Koseoglu RD, Parlaktas BS, Filiz NO, Erdemir F, Uluocak N, Tulunay O: Adenocarcinoma originating from a mature teratoma of the testis. Kaohsiung J Med Sci; 2007 May;23(5):265-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although testicular teratomas in childhood are regarded as benign neoplasms, these tumors, if left untreated until advanced ages, may present the risk of malignant transformation.
  • [MeSH-major] Adenocarcinoma / pathology. Teratoma / pathology. Testicular Neoplasms / pathology

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17525010.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 0 / Keratin-20; 0 / Keratin-7
  •  go-up   go-down


45. Pereira PD, Lopes CC, Matos AJ, Cortez PP, Gärtner F, Medeiros R, Lopes C: Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems. J Comp Pathol; 2010 Aug-Oct;143(2-3):87-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
  • Results obtained with both scoring methods were similar, revealing absence of immunoreactivity in normal luminal epithelium and in benign neoplasms and clearly associating Cav-1 expression with malignant transformation.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma / veterinary. Caveolin 1 / metabolism. Dog Diseases / diagnosis. Mammary Glands, Animal / metabolism. Mammary Neoplasms, Animal / diagnosis
  • [MeSH-minor] Animals. Caveolae / metabolism. Dogs. Female. Immunohistochemistry. Neoplasm Invasiveness. Neoplasm Metastasis. Prognosis. Research Design. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20153868.001).
  • [ISSN] 1532-3129
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Caveolin 1
  •  go-up   go-down


46. Viswanathan S, George S, Ramadwar M, Shet T, Arora B, Laskar S, Qureshi S, Medhi S, Muckaden MA, Kurkure PA, Kane SV, Banavali S: Extraconal orbital tumors in children--a spectrum. Virchows Arch; 2009 Jun;454(6):703-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraconal orbital tumors in children--a spectrum.
  • We analyzed 47 specimens comprising biopsies, excision specimens, and FNAC of extraconal pediatric orbital masses (excluding retinoblastoma) accessioned in the pathology department over 5 years in a tertiary referral cancer center.
  • The chief presenting symptom was proptosis in 55.3% patients and radiologically 53.8% malignant tumors showed extraorbital extension.
  • Malignant round cell tumors (76.6%), chiefly embryonal rhabdomyosarcoma (51%), benign spindle cell neoplasms, and infectious lesions (tuberculosis, fungal infections), were seen.
  • Of the malignant tumors, those confined to the orbit achieved good treatment response and had an event-free follow-up while those with extraorbital spread had poor outcome.
  • Pediatric orbital masses range from completely treatable infectious lesions, surgically resectable benign neoplasms to aggressive malignancies requiring chemotherapy and radiotherapy.
  • Pathologists play a key role in distinguishing these on small biopsy material and expediating accurate treatment thus saving the vision or life of a patient.
  • [MeSH-major] Orbital Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Algorithms. Biomarkers, Tumor / analysis. Child. Child, Preschool. Exophthalmos / diagnosis. Female. Humans. Infant. Male. Mycoses / diagnosis. Mycoses / therapy. Rhabdomyosarcoma, Embryonal / chemistry. Rhabdomyosarcoma, Embryonal / diagnosis. Rhabdomyosarcoma, Embryonal / secondary. Tuberculosis / diagnosis. Tuberculosis / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ophthalmology. 2004 May;111(5):997-1008 [15121380.001]
  • [Cites] J Emerg Med. 1999 Jul-Aug;17(4):641-5 [10431954.001]
  • [Cites] J Clin Pathol. 2003 Jun;56(6):412-6 [12783965.001]
  • [Cites] Pediatr Clin North Am. 2003 Feb;50(1):149-72 [12713110.001]
  • [Cites] Acta Cytol. 2006 Jan-Feb;50(1):88-92 [16514847.001]
  • [Cites] Surv Ophthalmol. 2003 Jan-Feb;48(1):39-57 [12559326.001]
  • [Cites] Ophthalmology. 1986 Mar;93(3):379-84 [3703507.001]
  • [Cites] Neuroimaging Clin N Am. 2005 Feb;15(1):121-36 [15927864.001]
  • [Cites] Br J Ophthalmol. 1997 Dec;81(12):1084-8 [9497470.001]
  • [Cites] J Pediatr Ophthalmol Strabismus. 2007 Mar-Apr;44(2):106-11 [17410962.001]
  • [Cites] Cancer. 1988 Jan 15;61(2):209-20 [3275486.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2008 Jul;72(7):971-5 [18499271.001]
  • [Cites] Arch Ophthalmol. 1998 Feb;116(2):243-6 [9488282.001]
  • [Cites] Am J Ophthalmol. 1978 Mar;85(3):407-18 [655220.001]
  • [Cites] Cancer. 1981 Oct 15;48(8):1807-18 [7284977.001]
  • [Cites] Am J Ophthalmol. 1994 Feb 15;117(2):177-82 [8116746.001]
  • [Cites] Trans Am Ophthalmol Soc. 2001;99:133-42; discussion 142-3 [11797301.001]
  • [Cites] Clin Radiol. 1998 May;53(5):357-62 [9630275.001]
  • [Cites] J Pediatr Hematol Oncol. 2008 Jun;30(6):474-7 [18525469.001]
  • [Cites] J Clin Oncol. 2001 Jun 15;19(12):3091-102 [11408506.001]
  • [Cites] Cancer. 1994 Jan 15;73(2):399-405 [8293407.001]
  • [Cites] Radiographics. 2007 Nov-Dec;27(6):1777-99 [18025517.001]
  • [Cites] Am J Ophthalmol. 1975 Dec;80(6):975-90 [1060381.001]
  • [Cites] Radiographics. 2008 Jul-Aug;28(4):1193-214 [18635637.001]
  • [Cites] Jpn J Ophthalmol. 2005 Jan-Feb;49(1):49-55 [15692775.001]
  • (PMID = 19421774.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


47. McBride SM, Haas-Kogan DA: Nutrient-sensitive, antagonistically pleiotropic genes and their contribution to malignant behavior. Med Hypotheses; 2008;70(2):444-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Consequently, we reasoned that the initiating genetic lesions seen in some of the Phakomatoses, disorders associated with predominantly benign neoplasms, may somehow fundamentally limit malignant behavior (invasion and metastasis).
  • We argue that inactivating mutations in these genes (labeled RPPMs: repressors of proliferation/promoters of motility) results in predominantly benign growths because, while such mutations promote unconstrained proliferation, they limit the ability of neoplastic cells to migrate and invade.
  • Such pleiotropy may represent an evolutionarily conserved strategy designed to limit the spread of nascent neoplasias.
  • When not inactivated, we show how selective pressures in the tumor microenvironment would suppress mutation in these genes during progression and how wild-type RPPMs may function synergistically with oncogenes to promote malignant behavior.
  • Finally, we explore how this model may help to explain oncogene addiction, tumor dormancy, and spontaneous regression.
  • [MeSH-major] Neoplasms / genetics
  • [MeSH-minor] Animals. Cell Movement / genetics. Humans. Models, Biological. Mutation. Neoplasm Invasiveness / genetics. Neoplasm Metastasis / genetics. Oncogenes. Polymorphism, Genetic. Tuberous Sclerosis / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17689876.001).
  • [ISSN] 0306-9877
  • [Journal-full-title] Medical hypotheses
  • [ISO-abbreviation] Med. Hypotheses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


48. Grady WM: Epigenetic events in the colorectum and in colon cancer. Biochem Soc Trans; 2005 Aug;33(Pt 4):684-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colon cancers arise from benign neoplasms and evolve into adenocarcinomas through a stepwise histological progression sequence, proceeding from either adenomas or hyperplastic polyps/serrated adenomas.
  • CGI DNA methylation is an epigenetic mechanism that represses gene transcription in normal cellular processes, but it becomes excessive and aberrant in many neoplasms.
  • These hypermethylated genes are not only probable pathogenic events affecting colon-cancer formation, but also neoplasm-specific molecular events that may be useful as molecular markers for colon tumours.
  • Furthermore, aberrant DNA methylation of tumour-suppressor genes may occur secondary to a genetic predisposition or to a field-cancerization effect in the colon and may be useful as molecular markers for the risk of developing colon cancer.
  • [MeSH-major] Colon / physiology. Colonic Neoplasms / genetics. Epigenesis, Genetic / genetics. Rectum / physiology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16042574.001).
  • [ISSN] 0300-5127
  • [Journal-full-title] Biochemical Society transactions
  • [ISO-abbreviation] Biochem. Soc. Trans.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Genetic Markers
  • [Number-of-references] 33
  •  go-up   go-down


49. Müller CS, Tilgen W, Kutzner H, Pföhler C: Recurring mixed-type neurothekeoma of the face. Dermatoendocrinol; 2009 Jul;1(4):220-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Neurothekeomas are rare, benign neoplasms, typically occurring in younger patients with a remarkable predilection for the female population.
  • The nomenclature and derivation of these tumors is controversial.
  • The rarity of this unusual skin tumor in daily routine histopathologic findings prompted the following report.
  • Multiple treatments with laser surgery were performed and yielded no persistent remission of the tumor.
  • Histopathologic examination revealed a non-encapsulated dermal tumor, composed of multiple, closely situated medium-sized nodules, separated by a myxoid collagenrich stroma, without epidermal alteration.
  • In summary, due to the histoarchitecture and immunoprofile of the tumor, a mixed-type cellular neurothekeoma was diagnosed.
  • The aim of this report is to help to avoid misdiagnoses of malignant mesenchymal tumors with serious consequences, including extensive surgical therapy or radiation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1998 May;32(5):414-22 [9639116.001]
  • [Cites] Pathologe. 1999 Mar;20(2):98-109 [10320997.001]
  • [Cites] Mod Pathol. 2004 Feb;17(2):230-4 [14685254.001]
  • [Cites] Am J Surg Pathol. 2007 Mar;31(3):329-40 [17325474.001]
  • [Cites] Histopathology. 1992 May;20(5):397-404 [1587488.001]
  • [Cites] Dermatol Surg. 2005 Jun;31(6):720-2 [15996430.001]
  • [Cites] Am J Surg Pathol. 2007 Jul;31(7):1103-14 [17592278.001]
  • (PMID = 20592794.001).
  • [ISSN] 1938-1980
  • [Journal-full-title] Dermato-endocrinology
  • [ISO-abbreviation] Dermatoendocrinol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2835878
  • [Keywords] NOTNLM ; cellular / nerve sheath tumor / neurothekeoma / skin / soft tissue tumor
  •  go-up   go-down


50. Sanz OA, Martinez PR, Guarch RT, Goñi MJ, Alcazar JL: Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient. Maturitas; 2007 Jun 20;57(2):214-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
  • BACKGROUND: Leydig cell tumours of the ovary are very rare benign neoplasms, frequently associated with symptoms of virilisation, in postmenopausal patients.
  • A 77-year-old postmenopausal patient was referred from the Endocrinology Service due to a biochemical diagnosis of hyperandrogenism during hospital admission with unbalanced diabetes mellitus.
  • A CT scan demonstrated adrenal glands and ovaries without tumour.
  • RESULT: The pathological finding was a bilateral Leydig cell tumour, measuring 15 mm in the right ovary and 3 mm in the left ovary.
  • [MeSH-major] Leydig Cell Tumor / diagnosis. Ovarian Neoplasms / diagnosis. Virilism / etiology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Postmenopause

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17289310.001).
  • [ISSN] 0378-5122
  • [Journal-full-title] Maturitas
  • [ISO-abbreviation] Maturitas
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


51. Woertler K: Soft tissue masses in the foot and ankle: characteristics on MR Imaging. Semin Musculoskelet Radiol; 2005 Sep;9(3):227-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Benign neoplasms and tumor-like lesions constitute the majority of soft tissue masses in the foot and ankle.
  • Therefore, malignant tumors are often unsuspected at this site and misdiagnosed clinically, especially if occurring in young individuals with unspecific or long-standing clinical symptoms.
  • In addition to radiography, MR imaging represents the method of choice in evaluation of foot tumors.
  • Because of their relatively characteristic imaging appearance, in most cases of benign soft tissue lesions of the foot and ankle a specific diagnosis can be suggested.
  • Unfortunately, malignant tumors can also arise with nonaggressive imaging features.
  • This article reviews the MR appearance of the most common benign and malignant soft tissue masses in the foot and ankle together with their clinical, radiographic, and pathological findings.
  • [MeSH-major] Ankle. Foot Diseases / diagnosis. Magnetic Resonance Imaging. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Angiomyoma / diagnosis. Chondroma / diagnosis. Chondromatosis, Synovial / diagnosis. Fibroma / diagnosis. Fibromatosis, Aggressive / diagnosis. Fibrosis / diagnosis. Ganglion Cysts / diagnosis. Hemangioma / diagnosis. Humans. Lipoma / diagnosis. Sarcoma, Clear Cell / diagnosis. Sarcoma, Synovial / diagnosis. Synovitis, Pigmented Villonodular / diagnosis

  • MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16247723.001).
  • [ISSN] 1089-7860
  • [Journal-full-title] Seminars in musculoskeletal radiology
  • [ISO-abbreviation] Semin Musculoskelet Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 62
  •  go-up   go-down


52. Lerman M, Freedman PD: Nonneural granular cell tumor of the oral cavity: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar;103(3):382-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonneural granular cell tumor of the oral cavity: a case report and review of the literature.
  • Nonneural granular cell tumors (NNGCTs) are rare benign neoplasms originally described in 1991 by Leboit et al.
  • Typical granular cell tumors (GCTs) are commonly encountered in the oral cavity, but NNGCTs, unlike GCTs, are S-100 negative and may display cytologic atypia, allowing for misdiagnosis as a more aggressive lesion.
  • We report a case of a 43-year-old male with a lesion of the mandible that we believe to be the first intraoral example of an NNGCT.
  • [MeSH-major] Granular Cell Tumor / pathology. Mandibular Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17321450.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD; 0 / Antigens, CD63; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD63 protein, human; 0 / CD68 antigen, human; 0 / Platelet Membrane Glycoproteins
  • [Number-of-references] 9
  •  go-up   go-down


53. Lasota J, Wang ZF, Sobin LH, Miettinen M: Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. Mod Pathol; 2009 Aug;22(8):1049-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases.
  • The inflammatory fibroid polyp is a rare benign lesion occurring throughout the digestive tract.
  • There were 26 deletions, three deletion-insertions, duplication, and single nucleotide substitution in exon 12, and a single nucleotide substitution and deletion in exon 18.
  • However, 1835_1852delinsCGC leading to the same S566_E571delinsR, were found in two tumors.
  • Similar gain-of-function PDGFRA mutations reported in gastrointestinal stromal tumors have been considered to be a driving pathogenetic force.
  • This study showed consistent expression and common mutational activation of PDGFRA in small intestinal inflammatory fibroid polyps as in their gastric counterparts, and these lesions should be considered PDGFRA-driven benign neoplasms.
  • [MeSH-major] Biomarkers, Tumor / genetics. Intestinal Neoplasms / genetics. Intestinal Polyps / genetics. Leiomyoma / genetics. Receptor, Platelet-Derived Growth Factor alpha / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. DNA Mutational Analysis. Female. Gastrointestinal Stromal Tumors / genetics. Humans. Immunohistochemistry. Intestine, Small / pathology. Male. Middle Aged. Mutation. Polymerase Chain Reaction. Young Adult

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • Genetics Home Reference. consumer health - PDGFRA gene.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19448595.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha
  •  go-up   go-down


54. Akgün RC, Güler UÖ, Onay U: A glomus tumor anterior to the patellar tendon: a case report. Acta Orthop Traumatol Turc; 2010;44(3):250-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A glomus tumor anterior to the patellar tendon: a case report.
  • Glomus tumors are benign neoplasms originating from the glomus body.
  • They are most frequently found in the nail bed of the hands, and their occurrence in other parts of the body is rare.
  • Plain radiographs showed no pathology other than mild degenerative changes.
  • The mass was excised and the histopathological diagnosis was reported as glomangioma.
  • [MeSH-major] Glomus Tumor / diagnosis. Patellar Ligament
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21088468.001).
  • [ISSN] 1017-995X
  • [Journal-full-title] Acta orthopaedica et traumatologica turcica
  • [ISO-abbreviation] Acta Orthop Traumatol Turc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


55. Marulaiah M, Gilhotra A, Moore L, Boucaut H, Goh DW: Testicular and paratesticular pathology in children: a 12-year histopathological review. World J Surg; 2010 May;34(5):969-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In all, 442 patients had non-neoplastic pathology, with 60.4% presenting acutely.
  • The most common non-neoplastic pathologies were hydatid of Morgagni (42.6%) and "vanishing testis" (14.3%).
  • A total of 32 patients had neoplasms.
  • Of 27 patients with testicular neoplasms, 55.6% were malignant (29.6% primary and 26% secondary), the principal primary malignancy was yolk sac tumor; the most common benign neoplasms were epidermoid cysts and teratomas.
  • Five patients had paratesticular neoplasms, with rhabdomyosarcoma in 80%.
  • CONCLUSIONS: The variety of scrotal and testicular pathology in children is considerable, with acute pathologic conditions comprising the bulk in the older (7-15 years) children, whereas impalpable testes and neoplasms comprise most of the lesions in infants.
  • Benign testicular neoplasms occur more frequently than primary malignancies.

  • MedlinePlus Health Information. consumer health - Testicular Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2003 Dec;170(6 Pt 1):2412-5; discussion 2415-6 [14634440.001]
  • [Cites] Pediatr Surg Int. 2007 Jan;23(1):41-4 [17031713.001]
  • [Cites] Pediatr Surg Int. 2007 Sep;23(9):867-72 [17639422.001]
  • [Cites] J Urol. 2002 Oct;168(4 Pt 2):1675-8; discussion 1678-9 [12352332.001]
  • [Cites] S Afr Med J. 1997 Dec;87(12):1696-8 [9497837.001]
  • [Cites] Pediatr Surg Int. 2002 Sep;18(5-6):435-7 [12415374.001]
  • [Cites] J Urol. 1993 Aug;150(2 Pt 2):667-9 [8326618.001]
  • [Cites] J Pediatr Surg. 2001 Dec;36(12):1796-801 [11733909.001]
  • [Cites] Pediatr Surg Int. 2006 May;22(5):413-6 [16602024.001]
  • [Cites] Med Princ Pract. 2005 May-Jun;14 (3):177-81 [15863992.001]
  • [Cites] J Pak Med Assoc. 2000 Apr;50(4):110-3 [10851829.001]
  • [Cites] Aust N Z J Surg. 1999 Jul;69(7):505-8 [10442922.001]
  • [Cites] Pediatr Clin North Am. 1998 Aug;45(4):813-30 [9728188.001]
  • [Cites] ANZ J Surg. 2003 Jan-Feb;73(1-2):55-8 [12534742.001]
  • [Cites] BJU Int. 2007 May;99(5):1123-6 [17437431.001]
  • [Cites] Indian J Pediatr. 2005 Mar;72 (3):201-203 [28378166.001]
  • (PMID = 20151127.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO, Thiis-Evensen E, Lothe RA: Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med; 2008;6:13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Tumor-derived aberrantly methylated DNA might serve as diagnostic biomarkers for cancer, but so far, few such markers have been identified.
  • The aim of the present study was to investigate the potential of the MAL (T-cell differentiation protein) gene as an early epigenetic diagnostic marker for colorectal tumors.
  • Immunohistochemical analysis of MAL was done using normal colon mucosa samples (n = 5) and a tissue microarray with 292 colorectal tumors.
  • CONCLUSION: Promoter hypermethylation of MAL was present in the vast majority of benign and malignant colorectal tumors, and only rarely in normal mucosa, which makes it suitable as a diagnostic marker for early colorectal tumorigenesis.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / genetics. DNA Methylation. Membrane Transport Proteins / genetics. Myelin Proteins / genetics. Proteolipids / genetics

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 2003 May 29;22(22):3463-71 [12776198.001]
  • [Cites] J Histochem Cytochem. 2003 May;51(5):665-74 [12704214.001]
  • [Cites] J Obstet Gynaecol Res. 2004 Feb;30(1):53-8 [14718022.001]
  • [Cites] Lancet. 2004 Apr 17;363(9417):1283-5 [15094274.001]
  • [Cites] Histol Histopathol. 2004 Jul;19(3):925-33 [15168355.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Apr;84(7):1997-2001 [3494249.001]
  • [Cites] Br J Cancer. 1991 Sep;64(3):475-80 [1911187.001]
  • [Cites] Cancer Res. 1998 Aug 1;58(15):3455-60 [9699680.001]
  • [Cites] J Cell Biol. 1999 Apr 5;145(1):141-51 [10189374.001]
  • [Cites] Cancer Res. 1999 May 1;59(9):2029-33 [10232580.001]
  • [Cites] Scand J Gastroenterol. 1999 Apr;34(4):414-20 [10365903.001]
  • [Cites] Cancer Res. 1999 Aug 1;59(15):3730-40 [10446989.001]
  • [Cites] Gastroenterology. 2005 Jan;128(1):192-206 [15633136.001]
  • [Cites] Neoplasia. 2005 Feb;7(2):99-108 [15802015.001]
  • [Cites] J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32 [16077070.001]
  • [Cites] Nat Rev Genet. 2006 Jan;7(1):21-33 [16369569.001]
  • [Cites] Gastroenterology. 2006 Sep;131(3):797-808 [16952549.001]
  • [Cites] Cell Oncol. 2006;28(5-6):259-72 [17167179.001]
  • [Cites] Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7 [17161655.001]
  • [Cites] Gastroenterology. 2007 Apr;132(4):1631-2; author reply 1632 [17408629.001]
  • [Cites] Dis Colon Rectum. 2007 Oct;50(10):1618-26; discussion 1626-7 [17762966.001]
  • [Cites] Cancer Res. 1993 Dec 15;53(24):5849-52 [8261392.001]
  • [Cites] Nucleic Acids Res. 1994 Aug 11;22(15):2990-7 [8065911.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6 [8790415.001]
  • [Cites] Cancer Res. 1997 Mar 1;57(5):808-11 [9041175.001]
  • [Cites] DNA Cell Biol. 1997 Mar;16(3):245-55 [9115633.001]
  • [Cites] Endocrinology. 1998 Apr;139(4):2077-84 [9528996.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870-5 [9618505.001]
  • [Cites] Nat Med. 1998 Jul;4(7):844-7 [9662379.001]
  • [Cites] Cancer Res. 2000 Aug 15;60(16):4366-71 [10969779.001]
  • [Cites] Lab Invest. 2001 Feb;81(2):217-29 [11232644.001]
  • [Cites] Nucleic Acids Res. 2001 Jul 1;29(13):E65-5 [11433041.001]
  • [Cites] Br J Cancer. 2002 Feb 12;86(4):574-9 [11870540.001]
  • [Cites] Bioinformatics. 2002 Nov;18(11):1427-31 [12424112.001]
  • [Cites] J Clin Oncol. 2003 Mar 1;21(5):820-9 [12610180.001]
  • [Cites] Nat Rev Cancer. 2003 Apr;3(4):253-66 [12671664.001]
  • [Cites] J Natl Cancer Inst. 2003 Dec 3;95(23):1747-57 [14652236.001]
  • (PMID = 18346269.001).
  • [ISSN] 1479-5876
  • [Journal-full-title] Journal of translational medicine
  • [ISO-abbreviation] J Transl Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MAL protein, human; 0 / Membrane Transport Proteins; 0 / Myelin Proteins; 0 / Myelin and Lymphocyte-Associated Proteolipid Proteins; 0 / Proteolipids
  • [Other-IDs] NLM/ PMC2292685
  •  go-up   go-down


57. Henning JS, Firoz BF: Combat dermatology: the prevalence of skin disease in a deployed dermatology clinic in Iraq. J Drugs Dermatol; 2010 Mar;9(3):210-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combat dermatology: the prevalence of skin disease in a deployed dermatology clinic in Iraq.
  • The most prevalent diagnoses included eczematous dermatitis [17%, n=462] and benign neoplasms [14%, n=375].
  • CONCLUSION: This is the largest publication of the prevalence of skin disease in an exclusively dermatologic clinic in a combat setting.
  • For the first time the presence of skin cancer is noted in a combat setting.
  • [MeSH-minor] Adolescent. Adult. Aged. Eczema / epidemiology. Female. Humans. Iraq War, 2003-2011. Male. Middle Aged. Prevalence. Skin Diseases, Infectious / epidemiology. Skin Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • MedlinePlus Health Information. consumer health - Veterans and Military Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20232580.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Pieta B, Opala T, Wilczak M, Grodecka-Gazdecka S, Kramer L, Samulak D, Wieznowska-Maczyńska K: Past obstetric history and risk of malignant breast neoplasms. Eur J Gynaecol Oncol; 2008;29(4):374-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Past obstetric history and risk of malignant breast neoplasms.
  • They are also probably responsible for the development of benign neoplasms and play a role in the origin and development of breast carcinoma.
  • The purpose of the study was to analyze the obstetrical past of patients and the potential influence on the risk of developing malignant breast neoplasms.
  • The participants in the study were healthy women with no changes in mammary glands (control group) and women with diagnosed malignant or benign breast neoplasms (study group).
  • Hormonal disorders in childhood and puberty symptoms of early menarche play a crucial role in increasing the risk of malignant breast neoplasms.
  • In women who experienced one or more miscarriages the risk of malignant breast neoplasms is significantly increased.
  • On the basis of our study we calculated the odds ratio (OR) of malignant breast neoplasms among women who during lactation experienced problems needing medical intervention (OR = 2.25; 95% CI, 1.20-4.19) in comparison to women who experienced no problems).
  • [MeSH-major] Breast Neoplasms / epidemiology. Reproductive History

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18714573.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Estrogens
  •  go-up   go-down


59. Passman C, Urban D, Klemm K, Lockhart M, Kenney P, Kolettis P: Testicular lesions other than germ cell tumours: feasibility of testis-sparing surgery. BJU Int; 2009 Feb;103(4):488-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Testicular lesions other than germ cell tumours: feasibility of testis-sparing surgery.
  • OBJECTIVE: To review all non-germ-cell testicular lesions presenting at our institution and to determine the feasibility of testis-sparing surgery for these patients.
  • The study comprised men who had radical orchidectomy for suspected germ-cell tumour but had other final pathology, and those where testis-sparing surgery was attempted for a presumed benign lesion.
  • The lesions could be categorized as inflammatory (three hyalinized fibrosis, two sarcoidosis, one chronic inflammation), cystic (one epidermoid cyst, one unilocular cyst), benign neoplasms (two adenomatoid tumours, one Leydig cell tumour, one capillary haemangioma) or malignant neoplasms (one lymphoma).
  • In the other five, testis-sparing surgery was not attempted because the preoperative impression was that of a germ cell tumour.
  • CONCLUSION: Testis-sparing surgery might be possible if there is significant suspicion of a benign lesion.
  • [MeSH-minor] Adolescent. Adult. Aged. Feasibility Studies. Humans. Leydig Cell Tumor / pathology. Leydig Cell Tumor / surgery. Leydig Cell Tumor / ultrasonography. Male. Middle Aged. Neoplasms, Germ Cell and Embryonal / pathology. Neoplasms, Germ Cell and Embryonal / surgery. Retrospective Studies. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Testicular Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18793303.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


60. Garg K, Lee P, Ro JY, Qu Z, Troncoso P, Ayala AG: Adenomatoid tumor of the adrenal gland: a clinicopathologic study of 3 cases. Ann Diagn Pathol; 2005 Feb;9(1):11-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomatoid tumor of the adrenal gland: a clinicopathologic study of 3 cases.
  • Adenomatoid tumors are relatively uncommon benign neoplasms of mesothelial origin, usually occurring in the male and female genital tracts.
  • Rare extragenital adenomatoid tumors have been identified in the adrenal glands, heart, mesentery, pleura, and lymph nodes.
  • In the adrenal gland, adenomatoid tumors may pose a diagnostic challenge.
  • The differential diagnosis includes adrenocortical carcinoma and metastatic carcinoma, especially signet ring cell carcinoma.
  • Because of its glandular pattern, an adenomatoid tumor may be confused with an adenocarcinoma.
  • We present 3 cases of adrenal adenomatoid tumors, including one with a concurrent large hemorrhagic vascular adrenal cyst.
  • The adenomatoid tumors were unilateral, appeared solid and white, and varied from 1.7 to 4.2 cm in diameter.
  • One patient presented with abdominal pain due to the presence of a concurrent large adrenal cyst.
  • The tumor was an incidental radiological finding in another case and was discovered during the course of a workup for hypertension in the third case.
  • The light microscopic appearances were consistent with those of typical adenomatoid tumors.
  • Immunohistochemical stains for calretinin and cytokeratin 5/6 were positive, confirming the tumors' mesothelial origin.
  • In our experience, the key to the diagnosis of this rare benign tumor is to consider adenomatoid tumor in the differential diagnosis of any glandular tumor occurring in the adrenal gland.
  • [MeSH-major] Adenoma / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adult. Biomarkers, Tumor / metabolism. Calbindin 2. Carcinoma, Signet Ring Cell / diagnosis. Carcinoma, Signet Ring Cell / secondary. Cysts / complications. Cysts / metabolism. Cysts / pathology. Diagnosis, Differential. Humans. Immunohistochemistry. Keratins / metabolism. Male. Middle Aged. S100 Calcium Binding Protein G / metabolism. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15692945.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G; 68238-35-7 / Keratins
  •  go-up   go-down


61. Novikov DV, Belova TV, Pegov RG, Aliasova AA, Morozova PN, Kniazev DI, Kalugin AV, Kontorshchikova KN, Baryshnikov AIu, Novikov VV: [Detection rate of MAGE-A1-A6 mRNA in the peripheral blood of cancer patients]. Klin Lab Diagn; 2009 Apr;(4):25-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mRNA expression of 6 MAGE-A (MAGE-A1-A6) antigens by the tumor focal cells and cancer cells circulating in blood was studied in solid malignant and benign neoplasms.
  • MAGE- A1-A6 mRNA expression was detected in the tumor focal cells in more than 90% of cases of cancer of the breast, lung, and stomach and melanoma cell lines.
  • The detection rate of peripheral blood MAGE-A1-A6-positive tumor cells was 95% in lung cancer, 53% in corpus uteri cancer, 67% in gastric cancer, 63% in breast cancer, 33% in melanoma, and 42% in uterine myoma.
  • [MeSH-major] Biomarkers, Tumor / blood. Neoplastic Cells, Circulating / metabolism. RNA, Messenger / blood
  • [MeSH-minor] Antigens, Neoplasm / blood. Female. Humans. Melanoma-Specific Antigens. Neoplasm Proteins / blood. Neoplasms / blood

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19514330.001).
  • [ISSN] 0869-2084
  • [Journal-full-title] Klinicheskaia laboratornaia diagnostika
  • [ISO-abbreviation] Klin. Lab. Diagn.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / MAGEA3 protein, human; 0 / MAGEA4 protein, human; 0 / MAGEA6 protein, human; 0 / Mage-a2 antigen; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / RNA, Messenger
  •  go-up   go-down


62. Rakic S, Nikolic B, Dragojevic-Dikic S: Ovarian neoplasms and pregnancy. Int J Gynecol Cancer; 2005 Nov-Dec;15(6):1120-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian neoplasms and pregnancy.
  • The aim of our study was to investigate the incidence of ovarian malignant neoplasms in pregnancy.
  • We examined 37 pregnant women; the incidence of ovarian cancer was 13.5% vs 6.5% in other works.
  • Treatment depends on the neoplasms type, grade, and presence of the metastatic pathways.
  • In benign neoplasms, we used laparoscopic treatment with minor invasion.
  • Distribution of benign neoplasms was in the same range as that in other works.
  • [MeSH-major] Ovarian Neoplasms / epidemiology. Pregnancy Complications, Neoplastic / epidemiology

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16343192.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Ridder GJ, Behringer S, Kayser G, Pfeiffer J: [Malignancies arising in sinonasal inverted papillomas]. Laryngorhinootologie; 2008 Nov;87(11):783-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Inverted papillomas are primarily benign neoplasms that occur in the nasal cavity and paranasal sinuses.
  • However, neither the etiology and pathogenesis of these tumors nor the putative role as a precursor to carcinoma and the factors responsible for associated malignancy have been clarified.
  • PATIENTS AND METHODS: In a retrospective study we reviewed the charts of 93 patients with sinonasal inverted papillomas who were treated at our department between 1990 and 2007.
  • Comparison was made between the group of patients with inverted papillomas and associated squamous cell carcinomas and the group of patients with benign inverted papillomas.
  • Our data suggest, that the association between carcinoma and inverted papilloma is indirect and that the gradual progression from inverted papilloma to a malignant neoplasm is if at all infrequent.
  • [MeSH-major] Carcinoma, Squamous Cell. Neoplasms, Multiple Primary. Neoplasms, Second Primary. Nose Neoplasms. Papilloma, Inverted. Paranasal Sinus Neoplasms. Sphenoid Sinus
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Maxillary Sinus / pathology. Maxillary Sinus Neoplasms / pathology. Maxillary Sinus Neoplasms / surgery. Middle Aged. Neoplasm Staging. Nose / pathology. Retrospective Studies. Risk Factors. Time Factors

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18633858.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


64. Chirieac LR, Dekmezian RH, Ayala AG: Characterization of the myxoid variant of hibernoma. Ann Diagn Pathol; 2006 Apr;10(2):104-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hibernomas are rare benign neoplasms composed of brown adipose tissue.
  • In this report, we present and characterize the spectrum of morphological features of the myxoid variant of hibernoma by describing the case of a 45-year-old white man who was referred to our hospital for treatment of an ovoid mass in the posterior segment of the right deltoid region.
  • Histopathologic examination of the resected specimen revealed a multilobulated, tan-yellow, variegated tumor with a rubbery consistency that was separated by thick fibrous septa with interspersed collections of foamy histiocytes.
  • This report highlights recent advances that may help confirm the diagnosis and explain the differential diagnosis of this rare tumor.
  • This is one of only a few cases of a myxoid variant of hibernoma reported in the literature.
  • [MeSH-major] Lipoma / diagnosis. Shoulder Joint
  • [MeSH-minor] Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry. Male

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16546046.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


65. Hirabayashi K, Yasuda M, Umemura S, Itoh H, Itoh J, Yazawa N, Imaizumi T, Osamura RY: Cytological features of the cystic fluid of pancreatic schwannoma with cystic degeneration. A case report. JOP; 2008;9(2):203-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Schwannomas are benign neoplasms arising from peripheral nerve tissue.
  • We present the histological and cytological features of a pancreatic schwannoma with cystic degeneration.
  • CASE REPORT: A 51-year-old male was diagnosed with a cystic tumor measuring approximately 6 cm in the tail of the pancreas.
  • Cystic fluid from the tumor was obtained intraoperatively by fine-needle aspiration, and it showed scattered spindle tumor cells against a background of hemosiderin-laden histiocytes.
  • During the operation, we informed the surgeon that the tumor consisted of "atypical spindle cells".
  • Histologically, the tumor was diagnosed as a schwannoma with cystic degeneration which had originated in the pancreas.
  • The diagnosis was confirmed by positive immunostaining of the tumor cells in both histological and cytological materials for S-100 protein.
  • CONCLUSION: Problems occasionally arise with the use of fine-needle aspiration in the diagnosis of cystic diseases of the pancreas because of the difficulty in obtaining adequate specimens.
  • Nevertheless, it should be emphasized that intraoperative fine-needle aspiration is as informative as a frozen section diagnosis, when appropriately performed.
  • [MeSH-major] Cyst Fluid / cytology. Neurilemmoma / pathology. Pancreas / pathology. Pancreatic Neoplasms / pathology

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18326930.001).
  • [ISSN] 1590-8577
  • [Journal-full-title] JOP : Journal of the pancreas
  • [ISO-abbreviation] JOP
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


66. Llauger J, Aixut S, Cañete N, Palmer J, Solà M, Bagué S: Meningioma of the scapula. Skeletal Radiol; 2008 Feb;37(2):169-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Meningiomas account for approximately 15% of all intracranial tumors and are the most common non-glial primary tumors of the central nervous system.
  • Most meningiomas are benign neoplasms with characteristic imaging features.
  • [MeSH-major] Bone Neoplasms / diagnosis. Meningioma / diagnosis. Scapula / diagnostic imaging. Scapula / pathology
  • [MeSH-minor] Aged, 80 and over. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Rare Diseases. Shoulder Pain / etiology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 2005 Sep;26(8):2053-6 [16155159.001]
  • [Cites] J Neurosurg. 2000 Dec;93(6):940-50 [11117866.001]
  • [Cites] Jpn J Clin Oncol. 2000 Jul;30(7):313-7 [11007165.001]
  • [Cites] Am J Surg Pathol. 1996 Apr;20(4):492-9 [8604818.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Aug;18(7):1335-7 [9282866.001]
  • [Cites] Hum Pathol. 1991 May;22(5):469-74 [1709609.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):453-60 [9130993.001]
  • [Cites] Ann Thorac Surg. 2006 May;81(5):1903-4 [16631706.001]
  • [Cites] Skeletal Radiol. 2001 Nov;30(11):639-42 [11810156.001]
  • (PMID = 18030466.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


67. Alvarez Ardura M, Hernández Cañas V, de la Morena Gallego JM, Rengifo Abbad D, González-Chamorro Ladrón de Guevara F, Llorente Abarca C: [Giant renal oncocytoma]. Actas Urol Esp; 2005 Sep;29(8):791-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Renal oncocytoma is a benign neoplasms arising from cells of the distal renal tubule.
  • They acount for 3-7% of all renal tumors. most are incidental findings.
  • Differential diagnosis with renal cells carcinoma is often difficult.
  • Here we report a case of big renal oncocytoma as an incidental finding while performing an abdominal ultrasound in a patient with low abdominal pain.
  • [MeSH-major] Adenoma, Oxyphilic / diagnostic imaging. Kidney Neoplasms / diagnostic imaging

  • Genetic Alliance. consumer health - Oncocytoma renal.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16304913.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas espanolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


68. Lochan R, Balupuri S, Bennett MK, Manas DM: Granular cell tumor as an unusual cause of obstruction at the hepatic hilum: report of a case. Surg Today; 2006;36(10):934-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granular cell tumor as an unusual cause of obstruction at the hepatic hilum: report of a case.
  • A diagnosis of malignancy is reasonably assumed when a lesion is found at the hilum or bile ducts in a patient with jaundice who has never undergone biliary surgery.
  • Although benign tumors occasionally develop in this location, preoperative recognition is difficult and most are treated as malignant lesions.
  • We illustrate this clinical scenario in this case report of a granular cell tumor (GCT) that developed at the biliary bifurcation, necessitating right hemi-hepatectomy with extrahepatic biliary tree excision.
  • We describe the clinical presentation, imaging findings, treatment, and histological findings of this tumor.
  • To our knowledge, this is the fourth report of a GCT at the hilum of the liver.
  • However, the possibility of this tumor should be considered in the differential diagnosis of a lesion in this location.
  • [MeSH-major] Bile Duct Neoplasms / complications. Cholestasis, Extrahepatic / etiology. Granular Cell Tumor / complications. Hepatic Duct, Common
  • [MeSH-minor] Cholangiography. Diagnosis, Differential. Female. Hepatectomy. Humans. Laparoscopy. Magnetic Resonance Imaging. Middle Aged

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Z Gastroenterol. 2004 Apr;42(4):323-5 [15095123.001]
  • [Cites] AMA Arch Pathol. 1952 Oct;54(4):398-402 [12984946.001]
  • [Cites] Dig Surg. 2000;17(3):299-303 [10867472.001]
  • [Cites] Br J Surg. 2001 Jan;88(1):48-51 [11136309.001]
  • [Cites] Am J Gastroenterol. 1988 Apr;83(4):432-4 [3348195.001]
  • [Cites] Gastroenterology. 1976 May;70(5 PT.1):779-82 [1261773.001]
  • [Cites] Surg Today. 2004;34(11):885-90 [15526120.001]
  • [Cites] Arch Pathol Lab Med. 1987 Feb;111(2):170-3 [3028314.001]
  • [Cites] Eur J Surg. 1996 Jul;162(7):551-4 [8874162.001]
  • (PMID = 16998691.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


69. Shrivastava RK, Epstein FJ, Perin NI, Post KD, Jallo GI: Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis. J Neurosurg Spine; 2005 Mar;2(3):249-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis.
  • OBJECT: Intramedullary spinal cord tumors (IMSCTs) in the older-age adult population pose complex management issues regarding the extent of resection and functional outcome, especially in terms of quality of life.
  • Ependymoma was the most common tumor (83%), and 55% were located in the thoracic spine.
  • There were two deaths due tumor progression (both malignant tumors) and one recurrence (anaplastic astrocytoma).
  • The longer prodromal period in the older adult population may reflect the fact that their diagnosis and workup is inadequate.
  • The authors recommend motor evoked potential-guided aggressive microsurgical resection, because the long-term outcome of benign lesions is excellent (good functional recovery and no tumor recurrence).
  • [MeSH-major] Ependymoma / surgery. Spinal Cord Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15796348.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Zhou YA, Huang JH, Wan CY, Zuo ZB: [Surgical treatment and effect observation of cervical intraspinal benign neoplasms]. Zhongguo Gu Shang; 2009 Nov;22(11):856-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment and effect observation of cervical intraspinal benign neoplasms].
  • OBJECTIVE: To investigate the diagnosis, surgical procedure and clinical outcome of cervical intraspinal benign neoplasm.
  • The tumors were removed completely in 18 cases, above 60% in 3 cases and 25% with biopsy in 1 case.
  • Cervical stability in 11 cases was restored after removal of tumors.
  • Symptoms improved in 20 cases and stable in 1 case and worsened in 1 case postoperatively according to JOA scoring system.
  • The average recover ratio of total was (46.7 +/- 2.46)%, cervical stability was (62.37 +/- 3.58)%, the other methods was (41.21 +/- 4.63)%.
  • CONCLUSION: The surgical exairesis for cervical intraspinal benign neoplasm has low post-operative recurrence.
  • The main reason of recurrence is not removed the tumor completely.
  • MRI is regarded the effective method which is helpful in differential diagnosis and surgery guidance.
  • [MeSH-major] Cervical Vertebrae / pathology. Cervical Vertebrae / surgery. Spinal Neoplasms / pathology. Spinal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20084949.001).
  • [ISSN] 1003-0034
  • [Journal-full-title] Zhongguo gu shang = China journal of orthopaedics and traumatology
  • [ISO-abbreviation] Zhongguo Gu Shang
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


71. Vernon SE, Casiano RR: Sphenoid sinus chondromyxoid fibroma mimicking a mucocele. Am J Otolaryngol; 2006 Nov-Dec;27(6):406-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report the case of a 44-year-old man who presented with a chondromyxoid fibroma (CMF) of the sphenoid sinus, which filled the sinus and clinically and radiologically resembled a mucocele.
  • Chondromyxoid fibromas are the least common cartilaginous neoplasms of bone, typically occurring in the metaphysis of long bones.
  • Chondromyxoid fibroma displays a relatively unique histological appearance, with characteristic lobulation, with spindle to stellate cells embedded in a myxoid or chondroid matrix.
  • Although CMFs are generally regarded as benign neoplasms, they may show an infiltrative pattern and may recur, particularly when they are in locations where complete surgical excision may be difficult or impossible.
  • [MeSH-major] Fibroma / diagnosis. Mucocele / pathology. Paranasal Sinus Neoplasms / diagnosis. Sphenoid Sinus / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17084225.001).
  • [ISSN] 0196-0709
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Redman RS, Katuri V, Tang Y, Dillner A, Mishra B, Mishra L: Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice. J Oral Pathol Med; 2005 Jan;34(1):23-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.
  • BACKGROUND: Smad4 is vital to the roles of Smads 2 and 3 in transforming growth factor-beta (TGF)-beta signal transduction, and inactivated Smad4 is common to human gastrointestinal cancers.
  • METHODS: Smad4+/- mice, known to develop gastrointestinal cancer, were crossbred with elf+/- mice.
  • RESULTS: In addition to polyps and adenocarcinomas of the stomach and duodenum, the smad4+/- mice developed squamous cell carcinomas of the skin, oral mucosa and forestomach, benign neoplasms of connective tissue and lacrimal gland, and a lymphoma.
  • The smad4+/-/elf+/- mice developed extensive hyperplasia and neoplasia of the gastric mucosa.
  • CONCLUSION: These findings indicate that investigating interactions among smad4, elf, and other genes involved in TGF-beta signaling should be useful in further delineating the processes of neoplasia in a wide variety of tissues.
  • [MeSH-major] Carcinoma, Squamous Cell / genetics. DNA-Binding Proteins / genetics. Neoplasms / genetics. Trans-Activators / genetics
  • [MeSH-minor] Animals. Female. Gastrointestinal Neoplasms / genetics. Hybridization, Genetic. Hyperplasia / genetics. Male. Mice. Mice, Mutant Strains. Mouth Neoplasms / genetics. Skin Neoplasms / genetics. Smad4 Protein

  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15610403.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01DK56111; United States / NIDDK NIH HHS / DK / R01DK58637
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Smad4 Protein; 0 / Trans-Activators
  •  go-up   go-down


73. Chittiboina P, Zhang S, Bao J, Vannemreddy P, Guthikonda B: Subependymoma at the foramen of Monro presenting with intermittent hydrocephalus: case report and review of the literature. J La State Med Soc; 2010 Jul-Aug;162(4):214-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Subependymomas are benign neoplasms, accounting for 0.5 % of all central nervous system tumors.
  • These tumors are frequently asymptomatic, often discovered incidentally at autopsy.
  • However, patients may be symptomatic with the symptoms depending on location of the tumor.
  • We present a rare case report of a subependymoma at the foramen of Monro presenting with intermittent hydrocephalus.
  • The patient's tumor was asymptomatic for many years.
  • Even though our patient presented with a histologically benign ventricular tumor, she demonstrated rapidly worsening symptoms that culminated in herniation.
  • Once diagnosed, we recommend early tumor removal and restoration of normal cerebrospinal fluid (CSF) pathways for these intraventricular tumors.
  • [MeSH-major] Brain Neoplasms / diagnosis. Cerebral Ventricles. Glioma, Subependymal / diagnosis. Hydrocephalus / etiology

  • Genetic Alliance. consumer health - Hydrocephalus.
  • Genetic Alliance. consumer health - Subependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Hydrocephalus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20882814.001).
  • [ISSN] 0024-6921
  • [Journal-full-title] The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
  • [ISO-abbreviation] J La State Med Soc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Seow-Choen F: The management of desmoids in patients with familial adenomatous polyposis (FAP). Acta Chir Iugosl; 2008;55(3):83-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Desmoids are benign neoplasms that are capable of infiltrating locally with a high risk of recurrence (25-65%) even after extirpating surgery.

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • Genetic Alliance. consumer health - Familial Polyposis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19069698.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Serbia
  • [Number-of-references] 21
  •  go-up   go-down


75. Manjunatha HK, Ramaswamy AS, Kumar BS, Kumar SP, Krishna L: Lipoleiomyoma of uterus in a postmenopausal woman. J Midlife Health; 2010 Jul;1(2):86-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoleiomyoma of uterus in a postmenopausal woman.
  • Lipoleiomyomas are uncommon benign neoplasms of uterus and are considered to be a variant of uterine myomas.
  • These tumors generally occur in asymptomatic obese perimenopausal or menopausal women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Korean Med Sci. 2001 Apr;16(2):250-2 [11306758.001]
  • [Cites] Pathology. 1991 Oct;23(4):360-2 [1784529.001]
  • [Cites] Int J Gynaecol Obstet. 1999 Oct;67(1):47-9 [10576241.001]
  • [Cites] Acta Pathol Jpn. 1991 Feb;41(2):164-9 [2042491.001]
  • [Cites] Pathol Res Pract. 1994 Apr;190(4):378-83 [8078806.001]
  • [Cites] Pathologica. 1996 Apr;88(2):132-4 [8927448.001]
  • (PMID = 21716761.001).
  • [ISSN] 0976-7819
  • [Journal-full-title] Journal of mid-life health
  • [ISO-abbreviation] J Midlife Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3122497
  • [Keywords] NOTNLM ; Lipoleiomyoma / menopause / smooth muscle / uterus
  •  go-up   go-down


76. Sucandy I, Sharma D, Dalencourt G, Bertsch DJ: Gallbladder neurofibroma presenting as chronic epigastric pain - Case report and review of the literature. N Am J Med Sci; 2010 Oct;2(10):496-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Benign nonepithelial neoplasms of the gallbladder are unusual.
  • In this study we report a case of gallbladder neurofibroma presenting as chronic epigastric pain in a young patient.
  • Physical examination, laboratory and radiologic workups were unremarkable for signs of biliary tract diseases.
  • Open conversion was necessitated because of the presence of a gallbladder mass preventing safe anatomic dissection.
  • CONCLUSIONS: Benign neoplasms such as gallbladder neurofibroma should be included in the differential diagnosis for chronic epigastric pain symptom in a young otherwise healthy patient with neurofibromatosis.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22558554.001).
  • [ISSN] 1947-2714
  • [Journal-full-title] North American journal of medical sciences
  • [ISO-abbreviation] N Am J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3339114
  • [Keywords] NOTNLM ; Neurofibroma / benign tumors / gallbladder
  •  go-up   go-down


77. Velnar T, Bunc G: Iatrogenic metastasis of a benign meningioma to the periosteum at the site of previous craniotomy: a case report. Wien Klin Wochenschr; 2008;120(23-24):766-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Iatrogenic metastasis of a benign meningioma to the periosteum at the site of previous craniotomy: a case report.
  • As far as we know, the presented case is the first report in the literature of iatrogenic seeding of a benign meningioma to the scalp following surgery.
  • A 37-year-old woman was admitted because of a relapsing meningioma in the frontal lobe.
  • At follow-up, three new masses were found: a bifrontal meningioma on the edge of the falx, a smaller one in the falx just under the saggital sinus and a small mass, believed to be ectopic, in the periosteum at the site of the previous craniotomy.
  • Histologically, the ectopic tumor was an atypical meningioma, similar to the one excised 10 years previously, with no relation to the other two intracranial masses.
  • Because of the histological similarity and the location in the old craniotomy, the ectopic tumor was believed to have developed from an implantation metastasis as a consequence of the first surgery.
  • The authors suggest that strict adherence to oncological principles should be applied in the case of benign neoplasms in order to prevent contamination of wounds with tumor cells and potential recurrence.
  • [MeSH-major] Craniotomy. Meningeal Neoplasms / surgery. Meningioma / secondary. Meningioma / surgery. Neoplasm Seeding. Neoplasms, Multiple Primary / surgery. Periosteum. Skull Neoplasms / secondary

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 2002 Sep;97(3):683-6 [12296654.001]
  • [Cites] Virchows Arch. 2001 Aug;439(2):196-200 [11561761.001]
  • [Cites] Br J Neurosurg. 1994;8(1):93-5 [8011202.001]
  • [Cites] Wien Klin Wochenschr. 1990 Sep 28;102(18):525-8 [2264343.001]
  • [Cites] Neurol Med Chir (Tokyo). 2004 Nov;44(11):600-2 [15686181.001]
  • [Cites] Wien Klin Wochenschr. 1975 Sep 19;87(17):560-3 [1189455.001]
  • [Cites] Neurol India. 2000 Mar;48(1):94-5 [10751830.001]
  • [Cites] Neurol Med Chir (Tokyo). 1993 Jul;33(7):458-62 [7692324.001]
  • [Cites] Virchows Arch. 2001 Mar;438(3):316-8 [11315631.001]
  • [Cites] Neurosurg Rev. 1998;21(4):295-8 [10068194.001]
  • [Cites] Oncology. 2002;62(4):386-8 [12138248.001]
  • [Cites] Br J Neurosurg. 2004 Aug;18(4):357-61 [15702834.001]
  • [Cites] Neurol Med Chir (Tokyo). 2007 Jan;47(1):36-9 [17245014.001]
  • (PMID = 19122989.001).
  • [ISSN] 0043-5325
  • [Journal-full-title] Wiener klinische Wochenschrift
  • [ISO-abbreviation] Wien. Klin. Wochenschr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


78. Harper L, Lavrand F, Le Bail B, Brun M, Ferron S, Oses P, Vergnes P: Glomus tumor of the mesocolon. J Pediatr Surg; 2005 Oct;40(10):e37-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Glomus tumor of the mesocolon.
  • Glomus tumors are rare distinctive benign neoplasms, which arise from modified smooth muscle cells of the normal glomus body and are most commonly located in the subungual region of the finger.
  • We report a case of glomus tumor of the mesocolon in a 10-year-old girl.
  • Histopathology showed it to be a glomus tumor of the mesocolon.
  • [MeSH-major] Glomus Tumor. Mesocolon. Peritoneal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16226974.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Park EA, Cho JY, Lee MW, Kim SH, Seong CK, Kim SH: MR features of fluid-fluid levels in ovarian masses. Eur Radiol; 2007 Dec;17(12):3247-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In non-teratomas, we assessed whether SI of the FFLs of benign masses and malignant neoplasms differed using the chi(2) test.
  • FFLs were observed in 66 of 556 ovarian masses (11.9%) on MR images, fat-fluid levels were observed in 11 of 80 teratomas, and FFLs attributed to hemorrhage in 54 of 476 non-teratomas and one twisted teratoma.
  • Non-neoplastic cystic lesions were most common non-teratomas to contain FFLs (27/197, 13.7%), followed by malignant neoplasms (23/177, 13.0%).
  • Benign neoplasms rarely contained FFLs (4/102, 3.9%); those that did were commonly associated with complications such as torsion or inflammation.
  • A hypointense supernatant layer together with a hyperintense dependent layer on T1-weighted images (T1WIs) was significantly more common in malignant neoplasms than in benign masses (P < 0.0001).
  • FFLs occurred in various ovarian masses ranging from benign to malignant neoplasms on MR images.
  • In non-teratomas, a hypointense supernatant layer and a hyperintense dependent layer on T1WIs may favor a diagnosis of malignancy.
  • [MeSH-minor] Adolescent. Adult. Aged. Chi-Square Distribution. Child. Contrast Media. Diagnosis, Differential. Female. Gadolinium DTPA. Humans. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Ovarian Disorders.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiographics. 2002 Nov-Dec;22(6):1305-25 [12432104.001]
  • [Cites] Magn Reson Imaging. 1993;11(4):595-7 [8316073.001]
  • [Cites] Acta Radiol. 1991 Jul;32(4):317-9 [1863504.001]
  • [Cites] Radiology. 1999 Jul;212(1):5-18 [10405714.001]
  • [Cites] Radiology. 1987 Mar;162(3):669-73 [3809479.001]
  • [Cites] J Comput Assist Tomogr. 1997 Nov-Dec;21(6):1001-4 [9386298.001]
  • [Cites] Radiographics. 1994 Nov;14 (6):1351-74; quiz 1375-6 [7855346.001]
  • [Cites] Radiology. 1994 Feb;190(2):337-41 [8284378.001]
  • [Cites] J Comput Assist Tomogr. 1987 Jul-Aug;11(4):664-9 [3597891.001]
  • [Cites] Radiology. 1991 Jul;180(1):73-8 [2052726.001]
  • [Cites] Radiology. 1990 Jan;174(1):73-8 [2294574.001]
  • [Cites] Radiology. 1984 Dec;153(3):819-20 [6494479.001]
  • [Cites] Radiology. 1989 Aug;172(2):515-20 [2748834.001]
  • [Cites] Eur Radiol. 2001;11(6):946-51 [11419167.001]
  • [Cites] Obstet Gynecol. 1989 Dec;74(6):921-6 [2685680.001]
  • [Cites] Radiographics. 2002 Mar-Apr;22(2):283-94 [11896219.001]
  • [Cites] AJR Am J Roentgenol. 1998 Oct;171(4):1061-5 [9762997.001]
  • [Cites] Eur Radiol. 2006 Dec;16(12):2687-99 [16547708.001]
  • [Cites] Radiographics. 2000 Sep-Oct;20(5):1445-70 [10992033.001]
  • [Cites] Eur Radiol. 2001;11(9):1770-83 [11511901.001]
  • [Cites] Abdom Imaging. 2002 Jan-Feb;27(1):100-5 [11740619.001]
  • [Cites] Radiographics. 2001 Mar-Apr;21(2):475-90 [11259710.001]
  • [Cites] Radiographics. 1994 Jul;14 (4):747-60; discussion 761-2 [7938766.001]
  • [Cites] Obstet Gynecol. 1994 Jul;84(1):22-8 [8008317.001]
  • [Cites] Br J Radiol. 1992 Jun;65(774):502-6 [1628182.001]
  • [Cites] Radiology. 1985 Jul;156(1):99-103 [4001427.001]
  • [Cites] Radiographics. 2001 Jan-Feb;21(1):193-216; questionnaire 288-94 [11158655.001]
  • [Cites] Radiology. 1994 Jun;191(3):759-64 [8184059.001]
  • [Cites] Radiology. 1985 Oct;157(1):87-93 [4034983.001]
  • [Cites] Radiology. 1993 Feb;186(2):481-8 [8421755.001]
  • (PMID = 17639405.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


80. Kaspareit J, Friderichs-Gromoll S, Buse E, Habermann G: Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period. Exp Toxicol Pathol; 2007 Nov;59(3-4):163-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period.
  • A total of 33 tumors were observed during a time period of 15 years (1992-2006) in cynomolgus monkeys.
  • The great majority of neoplasms was benign (23 benign neoplasms versus 10 malignant tumors).
  • The age of tumor-bearing animals ranged between 2 years 2 months and 13 years 9 months.
  • Most of the tumors (22) in the cynomolgus monkeys were seen in endocrine organs (adrenal cortical adenoma, adrenal hemangioma, C-cell carcinoma, follicular adenoma), respiratory system (nasal cavity adenoma, pulmonary squamous cell carcinoma, bronchio-alveolar carcinoma, bronchiolar papilloma, chondromatous hamartoma) and female genital system (uterine polyp, uterine adenoma, uterine leiomyoma and teratoma of the ovary).
  • [MeSH-major] Macaca fascicularis. Monkey Diseases / pathology. Neoplasms / veterinary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17869495.001).
  • [ISSN] 0940-2993
  • [Journal-full-title] Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie
  • [ISO-abbreviation] Exp. Toxicol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


81. Seidel A, Brunner S, Seidel P, Fritz GI, Herbarth O: Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br J Cancer; 2006 Jun 5;94(11):1726-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
  • To test their usefulness as tumour markers and to compare them with the conventional tumour markers, fractionated urine samples were analysed using chromatography.
  • The excretion patterns of nucleosides of 68 cancer patients with malignant and benign tumours and 41 healthy controls have been studied.
  • Significant elevations in the total sum and the concentrations of at least three (or four) of indicator nucleosides cytidine, pseudouridine, 2-pyridone-5-carboxamide-N1-ribofuranoside, N2,N2-dimethylguanine, 1-methylguanosine, 2-methylguanosine and 1-methyladenosine indicate a tumour with a sensitivity of 54% (77%) and a specificity of 86% (98%).
  • Using an artificial neural network analysis, a sensitivity of 97% and a specificity of 85% were achieved in differentiating between tumour and control volunteers.
  • The comparison with carcinoembryonic antigen, cancer antigen 15-3 und tissue polypeptide antigen indicates that urinary nucleosides may be useful tumour markers.
  • [MeSH-major] Biomarkers, Tumor / urine. Neoplasms / diagnosis. Neoplasms / urine. Nucleosides / urine
  • [MeSH-minor] Adult. Aged. Chromatography, High Pressure Liquid. Creatinine / urine. Female. Humans. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Staging. RNA, Neoplasm / analysis

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biomed Chromatogr. 2000 Nov;14(7):459-63 [11113924.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):27-33 [12383477.001]
  • [Cites] Cancer Res. 1977 Jan;37(1):285-92 [187335.001]
  • [Cites] Cancer Res. 1977 Sep;37(9):3362-6 [884680.001]
  • [Cites] J Clin Chem Clin Biochem. 1984 Dec;22(12):969-79 [6527105.001]
  • [Cites] Urol Res. 1985;13(5):213-8 [4060364.001]
  • [Cites] Hum Nutr Clin Nutr. 1986 Mar;40(2):103-18 [2420752.001]
  • [Cites] Verh Dtsch Ges Inn Med. 1986;92:114-20 [3811500.001]
  • [Cites] Gynecol Obstet Invest. 1986;22(4):212-7 [3817606.001]
  • [Cites] Acta Oncol. 1987;26(4):261-7 [3479987.001]
  • [Cites] Cancer Res. 1989 Feb 15;49(4):1057-62 [2912551.001]
  • [Cites] J Chromatogr. 1988 Dec 2;456(1):93-104 [3243873.001]
  • [Cites] Eur J Clin Nutr. 1990 Sep;44(9):647-58 [1702054.001]
  • [Cites] Scand J Urol Nephrol. 1993;27(1):45-53 [8493467.001]
  • [Cites] Cancer. 1993 Dec 15;72(12):3571-8 [8252470.001]
  • [Cites] Clin Chim Acta. 1993 Sep 17;218(1):73-82 [8299222.001]
  • [Cites] Clin Chim Acta. 1993 Sep 30;218(2):169-83 [7508341.001]
  • [Cites] Acta Oncol. 1995;34(1):61-7 [7865238.001]
  • [Cites] Tohoku J Exp Med. 1995 May;176(1):61-8 [7482520.001]
  • [Cites] Cancer Lett. 1996 Nov 29;108(2):157-62 [8973589.001]
  • [Cites] Leuk Lymphoma. 1998 Apr;29(3-4):383-9 [9684935.001]
  • [Cites] J Chromatogr A. 1998 Dec 18;828(1-2):489-96 [9916327.001]
  • [Cites] Rapid Commun Mass Spectrom. 2004;18(22):2730-8 [15499664.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):59-65 [15556516.001]
  • [Cites] Clin Biochem. 2005 Jan;38(1):24-30 [15607313.001]
  • (PMID = 16685264.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Nucleosides; 0 / RNA, Neoplasm; AYI8EX34EU / Creatinine
  • [Other-IDs] NLM/ PMC2361309
  •  go-up   go-down


82. Guzzo M, Ferrari A, Marcon I, Collini P, Gandola L, Pizzi N, Casanova M, Mattavelli F, Scaramellini G: Salivary gland neoplasms in children: the experience of the Istituto Nazionale Tumori of Milan. Pediatr Blood Cancer; 2006 Nov;47(6):806-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salivary gland neoplasms in children: the experience of the Istituto Nazionale Tumori of Milan.
  • BACKGROUND: Epithelial salivary gland tumors are very uncommon in pediatric age.
  • We report a series of 52 cases treated at the Istituto Nazionale Tumori of Milan, Italy, over a 30-year period.
  • These results are presented in conjunction with a literature review of salivary tumors with a view to providing an up-to-date overview of the clinical course, prognosis, and treatment options for this rare tumor.
  • PROCEDURE: Fifty-two cases of epithelial salivary tumors were reviewed and the clinical-pathological information concerning tumor characteristics, therapy, and follow-up were collected.
  • RESULTS: The major salivary glands were the main site of tumor occurrence (79% of cases arose in parotid glands); 37 patients had benign tumors (pleomorphic adenoma), 15 had malignant tumors (12 mucoepidermoid carcinoma, 9 low grade).
  • All the patients were treated by surgery; local relapses after parotidectomy were 4% and 25%, in benign and malignant tumors, respectively.
  • When tumor enucleation was performed, recurrences occurred in 50% of benign neoplasms.
  • At the time of the report, all patients with benign tumors were alive, 35(95%) without evidence of disease; only one patient with malignant tumor died of disease.
  • CONCLUSIONS: Epithelial salivary glands tumor in children had different characteristics compared with their adult counterpart with respect to the frequency of histotypes and site of occurrence, but their prognosis seems to be similar.
  • Parotidectomy (total or superficial) is the best choice for achieving good cure rates in both benign and malignant tumors.
  • [MeSH-major] Adenoma, Pleomorphic / surgery. Carcinoma, Acinar Cell / surgery. Carcinoma, Adenoid Cystic / surgery. Carcinoma, Mucoepidermoid / surgery. Neoplasm Recurrence, Local / surgery. Salivary Gland Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16425245.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Napal JJ, Hernández JL, Alonso J, Casuso E: [Differential factors of tumor etiology for iron deficiency anemia of probable gastrointestinal origin]. Rev Clin Esp; 2009 Jun;209(6):265-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Differential factors of tumor etiology for iron deficiency anemia of probable gastrointestinal origin].
  • [Transliterated title] Factores diferenciales de etiología tumoral de la anemia ferropénica de probable origen digestivo.
  • BACKGROUND: Diagnosis of iron deficiency anemia (IDA) of probably gastrointestinal (GI) tract origin is a difficult task for the clinician.
  • OBJECTIVE: To know the incidence of GI lesions in our setting; the possibility to predict cancer with clinical and laboratory parameters; the diagnostic utility of capsule endoscopy, and the follow-up in those patients.
  • There was 27 (20.9%) malignancies (21 colon, 5 stomach, 1 esophagus ); 39 (30.2%) benign upper GI lesions; 12 (9.3%) benign lower GI disorders; 16(12.4%) synchronous GI lesions; 2 (1.6%) celiac sprue, and 33 (25.6%) without identifiable lesions.
  • Diagnosis sensitivity of capsule endoscopy in obscure GI bleeding was 27%.
  • We did not found any malignancy during the follow-up of patients without an initial diagnosis.
  • We recommend a complete conventional GI endoscopic study if no evident bleeding lesion is found during the initial endoscopic procedure.
  • Capsule endoscopy and celiac disease serology are useful in obscure gastrointestinal bleeding.
  • [MeSH-major] Anemia, Iron-Deficiency / etiology. Gastrointestinal Hemorrhage / complications. Gastrointestinal Neoplasms / complications


84. Yancovitz M, Gonzalez ME, Votava HJ, Walters R, Kundu R, Shupack JL: Acquired smooth-muscle hamartoma. Dermatol Online J; 2009;15(8):12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cutaneous smooth-muscle hamartomas are uncommon benign neoplasms.
  • These lesions have been described as part of a spectrum of neoplasms that include Becker nevi since they share many clinical and histopathologic features.

  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19891920.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. González-Moles MA, Mosqueda-Taylor A, Delgado-Rodríguez M, Martínez-Mata G, Gil-Montoya JA, Díaz-Franco MA, Bravo-Pérez JJ, M-González N: Analysis of p53 protein by PAb240, Ki-67 expression and human papillomavirus DNA detection in different types of odontogenic keratocyst. Anticancer Res; 2006 Jan-Feb;26(1A):175-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To investigate the possible association between alterations in the p53 system and human papillomavirus (HPV) infection in the etiology of odontogenic keratocysts (OKCs) and to study proliferation and epithelial maturation patterns by topographic analysis of Ki-67 expression.
  • MATERIALS AND METHODS: Eighty-three OKC samples (29 cases associated with nevoid basal cell carcinoma syndrome, 29 solitary non-recurrent cases 20 solitary recurrent cases, and 5 chondroid keratocysts) were studied by immunohistochemistry to detect p53 protein (PAb 244) and Ki-67 (MIB-1) expression, and by PCR to detect HPV DNA.
  • OKCs show proliferation and genuine maturation behavior reminiscent of benign neoplasms with local destructive capacity.
  • [MeSH-major] DNA, Viral / analysis. Ki-67 Antigen / biosynthesis. Odontogenic Cysts / metabolism. Odontogenic Cysts / virology. Papillomaviridae / genetics. Tumor Suppressor Protein p53 / biosynthesis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16475695.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Ki-67 Antigen; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


86. Braunschweig T, Kaserer K, Chung JY, Bilke S, Krizman D, Knezevic V, Hewitt SM: Proteomic expression profiling of thyroid neoplasms. Proteomics Clin Appl; 2007 Mar;1(3):264-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proteomic expression profiling of thyroid neoplasms.
  • Thyroid cancer is the most common endocrine neoplasm with multiple histologic subtypes, each associated with different treatments and outcomes.
  • Differentiating benign neoplasms such as follicular adenomas from malignant entities such as follicular carcinomas and papillary carcinoma can be challenging.
  • To define the proteomic profile of different thyroid tumors, we screened an antibody array of 330 features against five thyroid neoplasms: follicular adenoma, follicular carcinoma, papillary carcinoma, anaplastic carcinoma, and medullary carcinoma as well as normal thyroid epithelium.
  • Eight candidate biomarkers; c-erbB-2, Stat5a, Annexin IV, IL-11, RARα, FGF7, Caspase 9, and phospho-c-myc were identified as differentially expressed on the antibody array, and validated with immunohistochemistry on tissue microarrays, with a total of 144 samples of the same variety of thyroid neoplasms.
  • Analysis revealed c-erbB-2, Annexin IV, and Stat5a have potential clinical utility to differentiate follicular adenoma, follicular carcinoma, and papillary carcinoma from each other.
  • By using an antibody array as a discovery platform and a tissue microarray as a first step in validation on a large number of specimens, we have identified new markers that have potential utility in the diagnosis of thyroid neoplasms.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
  • (PMID = 21136677.001).
  • [ISSN] 1862-8346
  • [Journal-full-title] Proteomics. Clinical applications
  • [ISO-abbreviation] Proteomics Clin Appl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Carney JA: Hyalinizing trabecular tumors of the thyroid gland: quadruply described but not by the discoverer. Am J Surg Pathol; 2008 Apr;32(4):622-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyalinizing trabecular tumors of the thyroid gland: quadruply described but not by the discoverer.
  • Hyalinizing trabecular tumors of the thyroid have been described on 4 occasions, by Carney and colleagues in 1987, by Ward and coworkers in 1982, by Pierre Masson in 1922, and by Rahel Zipkin in 1905.
  • Unaware of the 3 earlier descriptions, Carney and colleagues described 11 circumscribed or encapsulated thyroid tumors with elongated and polygonal cells arranged in trabeculae that contained a hyaline material resembling amyloid.
  • The nuclei of the tumor cells had cytoplasmic invaginations and grooves similar to those of papillary carcinoma.
  • Carney and colleagues labeled the neoplasms hyalinizing trabecular adenomas because of their microscopic appearance, absence of invasion, and benign natural history.
  • Subsequently, the nuclear features of the tumor and the molecular genetic findings led to the introduction of equivocal designations for it, hyalinizing trabecular tumor and hyalinizing trabecular neoplasm, and later to its designation as a variant of papillary carcinoma.
  • Experience has shown that most circumscribed or encapsulated follicular thyroid tumors with intratrabecular hyalin and nuclear features of papillary carcinoma behave as benign neoplasms.
  • Hyalinizing trabecular carcinoma is a very rare tumor.
  • [MeSH-major] Adenoma / pathology. Carcinoma, Papillary / pathology. Hyalin / metabolism. Terminology as Topic. Thyroid Gland / pathology. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18367942.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Historical Article; Journal Article; Portraits
  • [Publication-country] United States
  •  go-up   go-down


88. Hulsmann AR, de Bont N, den Hollander JC, Borgstein JA: Hamartomas of the oro- and nasopharyngeal cavity in infancy: two cases and a short review. Eur J Pediatr; 2009 Aug;168(8):999-1001
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hamartomas of the oro- and nasopharyngeal cavity in infancy: two cases and a short review.
  • INTRODUCTION: Oro- and nasopharyngeal masses are rare in infancy and consist of developmental anomalies and, mostly benign, neoplasms.
  • CASE REPORT: We report two infants with a tumour in the ear-nose-throat region.
  • [MeSH-major] Dermoid Cyst / pathology. Esophageal Neoplasms / pathology. Hamartoma / pathology. Oropharyngeal Neoplasms / pathology. Otorhinolaryngologic Diseases / pathology

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2007 Aug;31(8):1186-90 [17667541.001]
  • [Cites] Pediatr Surg Int. 2003 Nov;19(9-10):639-45 [14600772.001]
  • [Cites] AJR Am J Roentgenol. 2000 Aug;175(2):489-93 [10915701.001]
  • [Cites] Ear Nose Throat J. 1991 Jan;70(1):28-32 [2065616.001]
  • [Cites] J Laryngol Otol. 1989 Jun;103(6):612-5 [2769032.001]
  • [Cites] J Pediatr Surg. 1996 May;31(5):704-6 [8861486.001]
  • [Cites] Arch Pathol Lab Med. 2005 Nov;129(11):1444-50 [16253025.001]
  • (PMID = 18987884.001).
  • [ISSN] 1432-1076
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 77
  •  go-up   go-down


89. Mimatsu K, Oida T, Kawasaki A, Aramaki O, Kuboi Y, Katsura Y, Amano S: Preoperatively undetected solitary bile duct hamartoma (von Meyenburg complex) associated with esophageal carcinoma. Int J Clin Oncol; 2008 Aug;13(4):365-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bile duct hamartomas, also known as von Meyenburg complexes, are benign neoplasms consisting of cystic dilatation of the bile duct surrounded by fibrous stroma.
  • We report a rare case in a 60-year-old man who presented with coexistent von Meyenburg complex and esophageal carcinoma.
  • Preoperative computed tomography did not reveal any liver tumors.
  • As von Meyenburg complexes are small cystic lesions located throughout the liver, and as they do not present characteristic imaging findings, their preoperative morphological diagnosis and differential diagnosis from liver metastasis is extremely difficult.
  • In conclusion, von Meyenburg complex should be considered in the differential diagnosis of intrahepatic cystic neoplasms.
  • [MeSH-major] Bile Duct Diseases / diagnosis. Bile Ducts, Intrahepatic. Carcinoma, Squamous Cell / surgery. Esophageal Neoplasms / complications. Hamartoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Bile Duct Diseases.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1998 May-Jun;22(3):372-8 [9606376.001]
  • [Cites] Cancer. 1970 Aug;26(2):287-96 [4317963.001]
  • [Cites] World J Gastroenterol. 2006 Feb 28;12(8):1321-3 [16534895.001]
  • [Cites] Radiology. 2002 Oct;225(1):137-42 [12354997.001]
  • [Cites] Clin Imaging. 2007 Jan-Feb;31(1):50-3 [17189849.001]
  • [Cites] World J Gastroenterol. 2005 Oct 28;11(40):6354-9 [16419165.001]
  • [Cites] Am J Gastroenterol. 1980 Feb;73(2):113-9 [6249119.001]
  • [Cites] Hepatogastroenterology. 2003 Mar-Apr;50(50):333-6 [12749215.001]
  • [Cites] World J Gastroenterol. 2006 Jul 14;12(26):4250-2 [16830386.001]
  • [Cites] Mod Pathol. 1996 Mar;9(3):233-7 [8685220.001]
  • [Cites] Am J Gastroenterol. 1992 Feb;87(2):221-3 [1734702.001]
  • (PMID = 18704640.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


90. Ramana RK, Darki A, Havens M, Wojcik E, Brylka D, Singh MM, Leya F: Lipotamous cardiac disorders: two unsual cases and a review of the literature. J Invasive Cardiol; 2009 Apr;21(4):E65-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipotamous cardiac disorders: two unsual cases and a review of the literature.
  • Tumors involving the heart and surrounding cardiac structures may be benign or malignant and can be classified as primary versus secondary in etiology.
  • Primary cardiac tumors are rare lesions and the vast majority of these are benign neoplasms.
  • [MeSH-major] Cardiomyopathy, Hypertrophic / diagnosis. Heart Diseases / diagnosis. Heart Neoplasms / diagnosis. Lipomatosis / diagnosis

  • MedlinePlus Health Information. consumer health - Heart Disease in Women.
  • MedlinePlus Health Information. consumer health - Heart Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19342764.001).
  • [ISSN] 1557-2501
  • [Journal-full-title] The Journal of invasive cardiology
  • [ISO-abbreviation] J Invasive Cardiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human
  • [Number-of-references] 36
  •  go-up   go-down


91. Ang WM, Yates P, Robbins P, Wood D: Recurrent benign solitary intraosseous schwannoma of the tibia. Orthopedics; 2008 Feb;31(2):176
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent benign solitary intraosseous schwannoma of the tibia.
  • Schwannomas (neurilemmomas) are benign neoplasms composed of well-differentiated Schwann cells and are usually found in the soft tissues.
  • The occurrence of schwannomas in bone is rare, accounting for less than 0.2% of primary bone tumors.
  • We report the first case of a recurrent benign solitary intraosseous schwannoma of the tibia, and detail the clinical, radiological and histological findings.
  • [MeSH-major] Bone Neoplasms / radiography. Bone Neoplasms / surgery. Neoplasm Recurrence, Local / radiography. Neoplasm Recurrence, Local / surgery. Neurilemmoma / radiography. Neurilemmoma / surgery. Tibia / surgery

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19292192.001).
  • [ISSN] 0147-7447
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Dabholkar JP, Chhabria S, Mishra M, Chirmade S, Sikdar A: Benign laryngopharyngeal lesions: a case series. Indian J Otolaryngol Head Neck Surg; 2008 Mar;60(1):7-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign laryngopharyngeal lesions: a case series.
  • Benign neoplasms of the laryngopharynx are extremely rare.
  • While one was managed by conventional endoscopic route the other two required external approach.
  • All these cases highlights the need of a competent surgeon to treat benign laryngopharyngeal lesions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Otol Rhinol Laryngol. 2000 Mar;109(3):301-5 [10737315.001]
  • (PMID = 23120489.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450707
  • [Keywords] NOTNLM ; Laryngofissure / Microlaryngoscopy / Pharyngotomy / Schwannoma
  •  go-up   go-down


93. Keenan S, Bui-Mansfield LT: Musculoskeletal lesions with fluid-fluid level: a pictorial essay. J Comput Assist Tomogr; 2006 May-Jun;30(3):517-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The presence of fluid-fluid levels within a musculoskeletal lesion is an important finding, which can significantly aid in the differential diagnosis.
  • This finding can be observed in a wide variety of lesions: osseous and soft tissue masses, neoplastic or nonneoplastic lesions, malignant or benign neoplasms, and primary or metastatic malignancies.
  • When a fluid-fluid level is detected, in conjunction with clinical history, the differential diagnosis for a lesion can often be limited to a few choices.
  • We will review both osseous and soft tissue lesions, focusing on their imaging characteristics and other important findings.
  • [MeSH-major] Body Fluids. Magnetic Resonance Imaging. Musculoskeletal Diseases / diagnosis
  • [MeSH-minor] Bone Cysts / diagnosis. Bone Cysts, Aneurysmal / diagnosis. Bone Neoplasms / diagnosis. Chondroblastoma / diagnosis. Diagnosis, Differential. Fibrous Dysplasia of Bone / diagnosis. Humans. Lipoma / diagnosis. Osteosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16778633.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  •  go-up   go-down


94. Do TV, Kubba LA, Antenos M, Rademaker AW, Sturgis CD, Woodruff TK: The role of activin A and Akt/GSK signaling in ovarian tumor biology. Endocrinology; 2008 Aug;149(8):3809-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of activin A and Akt/GSK signaling in ovarian tumor biology.
  • We hypothesize that activin A plays a role in ovarian tumor biology, and analyzed activin-mediated pro-oncogenic signaling in vitro and the expression of activin signaling pathway molecules in vivo.
  • To validate in vitro observations, immunostaining of the betaA-subunit of activin A and phospho-GSKalpha/beta (Ser9/21) was performed, and the correlation between immunoreactivity levels of these markers and survival was evaluated in benign serous cystadenoma, borderline tumor, and cystadenocarcinoma microarrays.
  • Analysis of tissue microarrays revealed that betaA expression in epithelia did not correlate with survival or malignancy, but expression was elevated in stromal cells from carcinomas when compared with benign tumors.
  • Phospho-GSKalpha/beta (Ser9/21) staining was more intense in mitotically active carcinoma cells and exhibited a polarized localization in benign neoplasms that was absent in carcinomas.

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 2002 Jun;87(6):2644-57 [12050229.001]
  • [Cites] Cancer Res. 2001 Oct 15;61(20):7426-9 [11606375.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10 Suppl):200s-205s [12743135.001]
  • [Cites] J Obstet Gynaecol Can. 2003 Oct;25(10):834-44 [14532952.001]
  • [Cites] Oncol Rep. 2004 Mar;11(3):667-71 [14767519.001]
  • [Cites] Oncol Rep. 2004 Apr;11(4):875-9 [15010888.001]
  • [Cites] J Soc Gynecol Investig. 2004 May;11(4):203-6 [15120692.001]
  • [Cites] Neuron. 2004 Jun 24;42(6):897-912 [15207235.001]
  • [Cites] Reprod Biol Endocrinol. 2003 Oct 7;1:68 [14577833.001]
  • [Cites] J Exp Med. 2004 Sep 6;200(5):659-69 [15353558.001]
  • [Cites] Mol Cell Endocrinol. 2004 Oct 15;225(1-2):9-17 [15451562.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Feb;72(2):496-502 [1899424.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9267-71 [1409633.001]
  • [Cites] Int J Cancer. 1994 Feb 15;56(4):552-9 [8112891.001]
  • [Cites] Int J Cancer. 1995 Aug 22;64(4):280-5 [7657393.001]
  • [Cites] Endocrinology. 1996 Feb;137(2):486-94 [8593793.001]
  • [Cites] Hum Pathol. 1997 Jun;28(6):734-9 [9191009.001]
  • [Cites] J Biol Chem. 1998 May 22;273(21):13150-6 [9582355.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):99-102 [9916799.001]
  • [Cites] Int J Cancer. 1999 Apr 12;81(2):180-8 [10188716.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 11;96(10):5722-7 [10318951.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6249-54 [10339573.001]
  • [Cites] Mol Cell Biol. 2005 Jan;25(1):60-5 [15601830.001]
  • [Cites] Cell. 2005 Jan 14;120(1):123-35 [15652487.001]
  • [Cites] Mol Cancer Res. 2005 Jan;3(1):50-61 [15671249.001]
  • [Cites] Hum Mutat. 2005 Mar;25(3):322 [15712344.001]
  • [Cites] Clin Cancer Res. 2005 Apr 15;11(8):2875-8 [15837735.001]
  • [Cites] Int J Gynaecol Obstet. 2005 May;89(2):160-2 [15847888.001]
  • [Cites] Clin Cancer Res. 2005 Oct 15;11(20):7273-9 [16243797.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11649-57 [16357176.001]
  • [Cites] Endocrinology. 2006 Feb;147(2):724-32 [16282351.001]
  • [Cites] Cancer Lett. 2006 Jul 28;239(1):103-10 [16137825.001]
  • [Cites] Oncol Rep. 2006 Aug;16(2):373-9 [16820918.001]
  • [Cites] Adv Cancer Res. 2007;96:1-22 [17161674.001]
  • [Cites] Recent Results Cancer Res. 2007;174:91-100 [17302189.001]
  • [Cites] Hum Reprod Update. 2007 Mar-Apr;13(2):143-62 [17071638.001]
  • [Cites] Mol Cancer Res. 2008 May;6(5):695-705 [18505915.001]
  • [Cites] J Leukoc Biol. 2000 Mar;67(3):350-6 [10733095.001]
  • [Cites] Cancer Lett. 2000 May 29;153(1-2):137-43 [10779642.001]
  • [Cites] J Immunol. 2000 Sep 15;165(6):2997-3003 [10975808.001]
  • [Cites] BJOG. 2000 Sep;107(9):1069-74 [11002947.001]
  • [Cites] J Biol Chem. 2000 Nov 24;275(47):36803-10 [10969078.001]
  • [Cites] Trends Endocrinol Metab. 2000 Oct;11(8):309-14 [10996525.001]
  • [Cites] Endocr Rev. 2001 Apr;22(2):255-88 [11294827.001]
  • [Cites] Mol Cell Endocrinol. 2001 Mar 28;174(1-2):99-110 [11306176.001]
  • [Cites] Oncogene. 2001 Sep 20;20(42):5991-6000 [11593406.001]
  • [Cites] Biol Reprod. 2003 May;68(5):1877-87 [12606325.001]
  • (PMID = 18450971.001).
  • [ISSN] 0013-7227
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD044464; United States / NICHD NIH HHS / HD / HD044464
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / activin A; 104625-48-1 / Activins; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.26 / Glycogen Synthase Kinase 3
  • [Other-IDs] NLM/ PMC2488253
  •  go-up   go-down


95. Hever A, Roth RB, Hevezi PA, Lee J, Willhite D, White EC, Marin EM, Herrera R, Acosta HM, Acosta AJ, Zlotnik A: Molecular characterization of human adenomyosis. Mol Hum Reprod; 2006 Dec;12(12):737-48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenomyosis is a common gynaecological disorder characterized by the abnormal growth of endometrium into the myometrium and myometrial hypertrophy/hyperplasia.
  • Uterine fibroids are benign neoplasms of the myometrium, and they represent a diagnostic pitfall for adenomyosis.
  • Finally, we compared the gene expression profiles of adenomyosis and uterine fibroids and identified 471 differentially expressed probe sets that may represent potential biomarkers for the differential diagnosis of these diseases.
  • [MeSH-minor] Analysis of Variance. Biomarkers. Biomarkers, Tumor. Diagnosis, Differential. Endometrium / metabolism. Female. Humans. Leiomyoma / diagnosis. Leiomyoma / genetics. Leiomyoma / metabolism. Myometrium / metabolism. Neoplasm Proteins / biosynthesis. Neoplasm Proteins / genetics. Oligonucleotide Array Sequence Analysis. Principal Component Analysis. Uterine Neoplasms / diagnosis. Uterine Neoplasms / genetics. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Adenomyosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17020905.001).
  • [ISSN] 1360-9947
  • [Journal-full-title] Molecular human reproduction
  • [ISO-abbreviation] Mol. Hum. Reprod.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


96. Adeyemi BF, Kolude BM, Akang EE, Lawoyin JO: A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct;102(4):513-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors.
  • BACKGROUND: this study aimed at assessing the utility of silver nucleolar organizer region (AgNOR) staining in categorization and prognostication of salivary gland tumors.
  • METHODS: Twenty-seven malignant salivary gland tumors, 16 benign neoplasms, and 6 chronic sialadenitis lesions were stained using the technique described by Ploton et al. (1986).
  • RESULTS: The mean AgNOR counts for inflammatory lesions (1.67 +/- 0.19) and benign neoplasms (1.67 +/- 0.11), were less than for malignant neoplasms (3.59 +/- 0.55), P < .05.
  • There was no significant difference between the mean AgNOR counts of different specific histological types and grades of malignant neoplasms.
  • In addition, no correlation was found between mean AgNOR counts and the clinical course of malignant or benign salivary gland neoplasms.
  • CONCLUSION: Our results suggest that AgNOR staining is useful for distinguishing benign from malignant lesions, but is neither helpful for discriminating between histological types and grades of malignant neoplasms, nor prognostication of malignant salivary gland neoplasms.
  • [MeSH-major] Nucleolus Organizer Region / pathology. Salivary Gland Neoplasms / pathology. Silver Staining
  • [MeSH-minor] Adenocarcinoma / pathology. Adolescent. Adult. Aged. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Mucoepidermoid / pathology. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Sialadenitis / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Future Oncol. 2007 Feb;3(1):49-53 [17280501.001]
  • (PMID = 16997120.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. De Vincentiis M, Greco A, Mascelli A, Soldo P, Zambetti G: Lipoma of the larynx: a case report. Acta Otorhinolaryngol Ital; 2010 Feb;30(1):58-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lipoma is a benign tumour of mesenchymal origin with a very rare occurrence in the upper aero-digestive tract.
  • For a precise pre-operative diagnosis, indirect or direct laryngoscopy (flexible fibre-optic laryngoscopy) can be employed or, if necessary, also imaging techniques such as computed tomography scan and magnetic resonance imaging scan.
  • It is very important to completely remove these benign neoplasms in order to avoid local recurrence.
  • The present report referring to a case of laryngeal lipoma removed through an external surgical approach, aims to demonstrate that the choice of an external surgical approach is required for complete surgical removal of a large lipoma in order to prevent any possible recurrence.
  • [MeSH-major] Laryngeal Neoplasms. Lipoma

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Otol Rhinol Laryngol. 2000 Mar;109(3):301-5 [10737315.001]
  • [Cites] Auris Nasus Larynx. 2007 Dec;34(4):549-52 [17433592.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 2000 Nov;117(5):322-6 [11084406.001]
  • [Cites] Dysphagia. 2001 Summer;16(3):224-7 [11453572.001]
  • [Cites] Am Fam Physician. 2002 Mar 1;65(5):901-4 [11898962.001]
  • [Cites] Emerg Med J. 2002 May;19(3):275 [11971855.001]
  • [Cites] Laryngorhinootologie. 2002 Dec;81(12):887-9 [12486627.001]
  • [Cites] Otolaryngol Pol. 2002;56(6):669-74 [12577479.001]
  • [Cites] Arch Otolaryngol. 1973 Jun;97(6):495-6 [4704450.001]
  • [Cites] Arch Otolaryngol. 1973 Jul;98(1):55-7 [4713142.001]
  • [Cites] Plast Reconstr Surg. 1976 May;57(5):662-5 [1273146.001]
  • [Cites] Ear Nose Throat J. 1976 Nov;55(11):341-2 [1009863.001]
  • [Cites] Laryngoscope. 1982 Oct;92(10 Pt 1):1157-9 [7132517.001]
  • [Cites] Medicine (Baltimore). 1984 Jan;63(1):56-64 [6318013.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1985;47(1):17-21 [3969265.001]
  • [Cites] AJNR Am J Neuroradiol. 1986 Jul-Aug;7(4):657-64 [3088944.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1986 Dec;112(12):1289-92 [3768156.001]
  • [Cites] HNO. 1988 Apr;36(4):161-3 [3410753.001]
  • [Cites] Am J Surg Pathol. 1990 Feb;14(2):134-41 [2301699.001]
  • [Cites] Acta Otorhinolaryngol Ital. 1990 Jan-Feb;10(1):87-92 [2392926.001]
  • [Cites] Otolaryngol Head Neck Surg. 1990 Oct;103(4):653-7 [2123328.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Jan-Feb;12(1):19-24 [1846994.001]
  • [Cites] Ear Nose Throat J. 1991 Jun;70(6):387-8 [1893890.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1993 May-Jun;55(3):147-9 [8321547.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1994 Apr;103(4 Pt 1):315-8 [8154775.001]
  • [Cites] J Laryngol Otol. 1994 Feb;108(2):174-7 [8163927.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Apr;120(4):422-6 [8166973.001]
  • [Cites] Am J Otolaryngol. 1994 Mar-Apr;15(2):149-51 [8179107.001]
  • [Cites] J Laryngol Otol. 1995 Apr;109(4):353-7 [7782700.001]
  • [Cites] Laryngoscope. 1995 Jul;105(7 Pt 1):747-56 [7603280.001]
  • [Cites] Acta Otorrinolaringol Esp. 1995 Nov-Dec;46(6):457-8 [8554829.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1995 Nov-Dec;57(6):351-5 [8789488.001]
  • [Cites] Ear Nose Throat J. 1999 Feb;78(2):122-5; quiz 126-8 [10089698.001]
  • [Cites] AMA Arch Otolaryngol. 1952 Nov;56(5):524-31 [12996160.001]
  • [Cites] J Laryngol Otol. 2006 Jan;120(1):47-55 [16359147.001]
  • [Cites] Ear Nose Throat J. 2005 Nov;84(11):728, 730, 734 [16381139.001]
  • [Cites] J Laryngol Otol. 2000 Jan;114(1):58-60 [10789415.001]
  • (PMID = 20559475.001).
  • [ISSN] 1827-675X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2881609
  • [Keywords] NOTNLM ; Imaging / Larynx / Lipoma / Surgical techniques
  •  go-up   go-down


98. DeRoche T, Walker E, Magi-Galluzzi C, Zhou M: Pathologic characteristics of solitary small renal masses: can they be predicted by preoperative clinical parameters? Am J Clin Pathol; 2008 Oct;130(4):560-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor size, histologic type, Fuhrman nuclear grade, and stage were obtained from surgical pathology reports.
  • Clinical variables included age, sex, tumor size, and symptomatology.
  • Median tumor size was 2.6 cm (range, 0.5-4.0 cm).
  • Nonneoplastic entities, benign neoplasms, and low- and high-grade carcinoma accounted for 1.6%, 18.0%, 49.0%, and 31.4% of masses, respectively.
  • Women were more likely to have a benign mass (27.3% vs 14.5% of men, P < .001).
  • Age (P = .56), tumor size (mean, 2.63 vs 2.46 cm for benign; P = .08), and symptomatology (P = .46) were not associated with malignancy.
  • Multivariate analyses using sex, age, tumor size, and symptomatology failed to produce a model useful to predict the pathology of individual tumors.
  • [MeSH-major] Kidney Diseases / pathology. Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18794048.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Maruya S, Kies MS, Williams M, Myers JN, Weber RS, Batsakis JG, El-Naggar AK: Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol; 2005 Jul;36(7):821-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
  • To determine the association between the expression of p63 gene isoforms (TA and DeltaN) and salivary gland tumorigenesis, we performed reverse transcription-polymerase chain reaction analysis of these markers in 71 benign and malignant salivary gland neoplasms.
  • TAp63 was highly expressed in most benign tumors and was either negative or weakly positive in most carcinomas.
  • Conversely, DeltaNp63 was negative or faintly positive in most benign neoplasms and was highly expressed in adenoid cystic, mucoepidermoid, and myoepithelial carcinomas.
  • Immunohistochemical analysis using anti-full-length p63 protein showed ubiquitous nuclear staining in basal and myoepithelial cells in both benign and malignant neoplasms.
  • JAG1 was expressed in most benign and malignant tumors and did not correlate with p63 isoforms expression.
  • We conclude that (1) p63 isoforms are differentially expressed in most benign and malignant tumors and may play distinct biological roles in certain salivary gland neoplasms;.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenolymphoma / metabolism. Adenoma, Pleomorphic / metabolism. Genes, Tumor Suppressor. Phosphoproteins / metabolism. Salivary Gland Neoplasms / metabolism. Trans-Activators / metabolism
  • [MeSH-minor] Calcium-Binding Proteins. DNA Primers / chemistry. DNA-Binding Proteins. Gene Expression Regulation, Neoplastic. Humans. Immunoenzyme Techniques. Intercellular Signaling Peptides and Proteins. Membrane Proteins / genetics. Membrane Proteins / metabolism. Protein Isoforms. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction. Salivary Glands / metabolism. Salivary Glands / pathology. Transcription Factors. Tumor Suppressor Proteins

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16084953.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / DNA Primers; 0 / DNA-Binding Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / Phosphoproteins; 0 / Protein Isoforms; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / TP63 protein, human; 0 / Trans-Activators; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins; 134324-36-0 / Serrate proteins
  •  go-up   go-down


100. Bianchi LC, Marchetti M, Brait L, Bergantin A, Milanesi I, Broggi G, Fariselli L: Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery. Neurol Sci; 2009 Dec;30(6):479-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paragangliomas are highly vascular and predominantly benign neoplasms that have traditionally been treated by surgery, embolization and/or external beam radiotherapy (EBRT).
  • The aim of this study is to evaluate the short-term local tumor control and safety of CyberKnife radiosurgery for these lesions.
  • Eight patients were treated with doses ranging from 11 to 13 Gy (mean 12.5 Gy) in a single fraction and one with 24 Gy in three fractions prescribed to 72-83% isodose line.
  • [MeSH-major] Carotid Body Tumor / surgery. Glomus Jugulare Tumor / surgery. Head and Neck Neoplasms / surgery. Radiosurgery / methods

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):914-21 [16338096.001]
  • [Cites] Laryngoscope. 2007 Oct;117(10):1710-9 [17690614.001]
  • [Cites] Cancer. 1992 Apr 1;69(7):1813-7 [1551066.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(11):1141-6 [10592113.001]
  • [Cites] Head Neck. 1990 Jul-Aug;12(4):303-7 [2163370.001]
  • [Cites] Laryngoscope. 1994 Dec;104(12):1461-5 [7990634.001]
  • [Cites] Otol Neurotol. 2004 Jul;25(4):594-8; discussion 598 [15241240.001]
  • [Cites] Laryngoscope. 1995 Feb;105(2):115-26 [8544589.001]
  • [Cites] Head Neck. 2002 Apr;24(4):332-8; discussion 338-9 [11933174.001]
  • [Cites] Otol Neurotol. 2004 Jul;25(4):570-9; discussion 579 [15241237.001]
  • [Cites] Neurosurgery. 1999 Jun;44(6):1299-306; discussion 1306-7 [10371630.001]
  • [Cites] Acta Neurochir (Wien). 1994;130(1-4):66-70 [7725944.001]
  • [Cites] Laryngoscope. 1994 Aug;104(8 Pt 1):917-21 [8052073.001]
  • [Cites] Neurosurg Focus. 2004 Aug 15;17(2):E4 [15329019.001]
  • [Cites] Oncology (Williston Park). 1991 Apr;5(4):131-7; discussion 140, 143 [1651096.001]
  • [Cites] Laryngoscope. 1989 Dec;99(12):1244-7 [2557501.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1988 Nov-Dec;97(6 Pt 1):613-20 [2849359.001]
  • [Cites] Stereotact Funct Neurosurg. 2001;76(3-4):204-8 [12378098.001]
  • [Cites] Laryngoscope. 1987 Feb;97(2):152-7 [3027478.001]
  • [Cites] J Neurosurg. 1994 Jun;80(6):1026-38 [8189258.001]
  • [Cites] Neurosurgery. 2006 Sep;59(3):561-9; discussion 561-9 [16955038.001]
  • [Cites] Med Phys. 2008 May;35(5):2180-94 [18561693.001]
  • [Cites] Head Neck. 2008 Nov;30(11):1431-8 [18704974.001]
  • [Cites] Laryngoscope. 2000 Jan;110(1):35-8 [10646712.001]
  • [Cites] Skull Base Surg. 1996;6(3):147-52 [17170971.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1996 Dec;105(12):949-54 [8973281.001]
  • [Cites] Cancer. 2002 Feb 1;94(3):730-7 [11857306.001]
  • [Cites] J Neurosurg. 2005 Jan;102(s_supplement):241-246 [28306446.001]
  • [Cites] Neurosurg Focus. 2004 Aug 15;17(2):E11 [15329026.001]
  • [Cites] J Laryngol Otol. 2001 Jun;115(6):467-74 [11429070.001]
  • [Cites] Neurosurgery. 2003 Jan;52(1):140-6; discussion 146-7 [12493111.001]
  • [Cites] J Med Genet. 2002 Sep;39(9):617-22 [12205103.001]
  • [Cites] J Neurosurg. 2002 Dec;97(6):1356-66 [12507134.001]
  • [Cites] Laryngorhinootologie. 1991 Jun;70(6):284-8 [1872929.001]
  • [Cites] Cancer. 1984 Jun 15;53(12):2635-40 [6326988.001]
  • [Cites] Laryngoscope. 2006 Dec;116(12):2191-204 [17146395.001]
  • [Cites] Am J Otol. 1993 Jul;14 (4):398-402 [8238279.001]
  • [Cites] Acta Neurochir Suppl. 2002;84:91-7 [12379010.001]
  • [Cites] Am J Otol. 1995 May;16(3):283-9 [8588620.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] Technol Cancer Res Treat. 2007 Oct;6(5):419-23 [17877430.001]
  • [Cites] Laryngoscope. 1988 Mar;98(3):325-31 [2830447.001]
  • [Cites] Am J Surg. 1971 Dec;122(6):740-3 [4331408.001]
  • [Cites] Skull Base Surg. 1992;2(1):1-5 [17170873.001]
  • [Cites] Minim Invasive Neurosurg. 2001 Sep;44(3):141-6 [11696882.001]
  • [Cites] Otol Neurotol. 2001 May;22(3):377-82 [11347643.001]
  • [Cites] Laryngoscope. 1993 Nov;103(11 Pt 2 Suppl 60):23-7 [8231590.001]
  • [Cites] Neurosurg Clin N Am. 1992 Jan;3(1):51-9 [1633452.001]
  • (PMID = 19774334.001).
  • [ISSN] 1590-3478
  • [Journal-full-title] Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • [ISO-abbreviation] Neurol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down






Advertisement